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Abstract
Background This is the fourth updated Enhanced Recovery After Surgery (ERAS) Society guideline presenting a
consensus for optimal perioperative care in colorectal surgery and providing graded recommendations for each
ERAS item within the ERAS protocol.
Methods A wide database search on English literature publications was performed. Studies on each item within the
protocol were selected with particular attention paid to meta-analyses, randomised controlled trials and large
prospective cohorts and examined, reviewed and graded according to Grading of Recommendations, Assessment,
Development and Evaluation (GRADE) system.
Results All recommendations on ERAS protocol items are based on best available evidence; good-quality trials;
meta-analyses of good-quality trials; or large cohort studies. The level of evidence for the use of each item is
presented accordingly.
Conclusions The evidence base and recommendation for items within the multimodal perioperative care pathway are
presented by the ERAS Society in this comprehensive consensus review.
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Introduction
The Enhanced Recovery After Surgery (ERAS) Society
care pathways include evidence-based items designed to
reduce perioperative stress, maintain postoperative physi-
ological function and accelerate recovery after surgery.
Using such a multimodal stress-minimising approach has
been shown repeatedly to reduce rates of morbidity,
improve recovery and shorten length of stay (LOS) after
major colorectal surgery [1–7].
Since the first guidelines were published in 2005 [8],
more colorectal operations are being performed using
minimally invasive techniques. Furthermore, the evidence
base underpinning all perioperative care items is in con-
tinuous development, which necessitates frequent updates
of the knowledge base. This article represents the joint
efforts of the ERAS Society (www.erassociety.org) and
authors from other international ERAS chapters to present
an updated consensus review of perioperative care for
colorectal surgery based on best current evidence.
Methods
Literature search
Starting from our previous guidelines in colon [9] and rectal
[10] surgery published in 2013 the first and last author
identified topics for inclusion. International authors known
for their expertise in each item, respectively, and in overall
perioperative care were invited to participate in the work.
All invited authors accepted participation and received
instructions for the literature search. PubMed, Embase and
Cochrane databases were used to identify relevant contri-
butions from January 2012 (end date for the search in the
previously published guidelines [9]) and October 2017.
Keywords included ‘‘colon’’, ‘‘rectum’’, ‘‘enhanced
recovery’’, ‘‘ERAS’’ and ‘‘fast track’’. Meta-analyses ran-
domised controlled trials (RCTs) and prospective/retro-
spective cohort studies were considered for each
perioperative item. The individual authors screened titles
and abstracts in order to identify relevant articles. The first
and last author then repeated this procedure.
Quality assessment and data analyses
The Cochrane checklist [11] was used to assess method-
ological quality of the included studies. Quality of evi-
dence and recommendations were evaluated according to
the Grading of Recommendations, Assessment, Develop-
ment and Evaluation (GRADE) system. Quoting from the
GRADE statement [12–14], the recommendations are
given as follows:
Strong recommendations: The panel is confident that the
desirable effects of adherence to a recommendation out-
weigh the undesirable effects.
Weak recommendations: The desirable effects of
adherence to a recommendation probably outweigh the
undesirable effects, but the panel is less confident.
Recommendations are based on quality of evidence
(high, moderate, low) but also on the balance between
desirable and undesirable effects; and on values and pref-
erences of practitioners. Thus, strong recommendations
may be reached from low-quality data and vice versa.
One or two authors covered the evidence base for each
item. The quality of evidence for each item was then
reviewed and crosschecked by several other authors in the
author list.
Presentation
The evidence and recommendations for ERAS items are
presented in four different headings: preadmission, preop-
erative, intraoperative and postoperative and are numbered
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in the order they are to be used in clinical practice. A
summary figure (Figs. 1, 2, 3, 4) shows an overview of the
quality of evidence and grade of recommendation for each
phase of the perioperative course. Table 1 shows all the
ERAS items.
Evidence base and recommendations
Preadmission items
See Fig. 1.
1. Preadmission information, education and
counselling
Comprehensive preoperative counselling has several
important goals. First, as patients fear the unknown, proper
and complete information may reduce anaesthesia- and
surgery-related anxiety and subsequent pain [15–19]. Sec-
ondly, the patient’s preparedness, satisfaction and overall
surgical experience may be improved considerably by
detailed, procedure-specific and patient-centred information
giving sessions [20–22]. As a consequence of this psycho-
logical support, a positive impact of preoperative informa-
tion on LOS and postoperative outcomes has been reported
in an RCT and a Cochrane analysis [23, 24]. Modern edu-
cation strategies including multimedia or virtual reality
experiences may be considered [15, 25]. Patients and rela-
tives/carers should meet with a multidisciplinary team
comprising a surgeon, anaesthesiologist and most impor-
tantly a nurse or allied health professional, all whom have a
role in guiding the patient through the surgery-related
experience before admission to the hospital [26].
Summary and recommendation:
Patients should receive dedicated preoperative coun-
selling routinely.
Quality of evidence: Moderate (study quality, heteroge-
neous endpoints)
Recommendation grade: Strong
2. Preoperative optimisation
Risk assessment
There are several examples of preoperative risk assess-
ment scores proposed in the literature [27–30] but due to
the low level of evidence of these scores, their use is
limited. For instance, while it is generally believed that a
multidisciplinary team should evaluate patients with a high
risk of cardiac disease undergoing major surgery, the level
of evidence for this intervention is very low [29]. While
nutritional assessment and intervention seem to be useful
for the high-risk malnourished patients, there is only one
prospective study available [28]. For more general preop-
erative risk assessment tools, prospective data showing any
effect on outcomes are lacking [27]. Most commonly tools
describe control of systemic diseases such as optimisation
of heart disease, lung disease, kidney disease, hypertension,
diabetes, correction of derangements such as anaemia and
malnutrition, and cessation of excessive alcohol use and
smoking. This section refers to the latter two aspects,
which are mainly under the control of the patient.
Smoking cessation
Patients who smoke have an increased risk of intra- and
postoperative complications [31]. There are many methods
of achieving smoking cessation in different subsets of
patients, utilising pharmacologic versus behavioural therapy.
In the preoperative setting, there are several meta-analyses
[32–34] of preoperative smoking cessation, evaluating types
of intervention and postoperative complications. In the pre-
operative setting, intense counselling and nicotine replace-
ment therapy are most likely to be effective [33]. Although
the optimal preoperative intervention, duration and intensity
are unknown, 4–8 weeks of abstinence appear necessary to
reduce respiratory and wound-healing complications
[32, 34]. Even at the level of these meta-analyses, it is
unclear whether short-term (\ 4 weeks) smoking cessation
reduces the risk of postoperative respiratory complications.
Avoiding Alcohol Abuse
Observational studies suggest that alcohol abuse increa-
ses postoperative morbidity [35, 36]. A systematic review
and meta-analysis identified thirteen observational studies
and five RCTs [37] and showed that consumption of more
than two units (equal to a total of 50 ml spirits 40%, 150 ml
wine 13%, 500 ml 4% beer or alcopop (a ready-mixed drink
containing alcohol) of alcohol per day increases the rate of
postoperative infections, but not mortality. In the same paper
[37], a separate meta-analysis of the RCTs also confirmed
that interventions to reduce alcohol intake reduce infections
but not mortality. The impact on patients with lesser alcohol
intake is unknown. Preoperative abstinence of 4 weeks is
recommended [37]. Another review [38] found only two
RCTs evaluating the effect of intensive alcohol cessation
interventions (69 patients). Intensive preoperative alcohol
cessation interventions, including pharmacological strategies
for prophylaxis of relapse and withdrawal symptoms, may
reduce postoperative complication rates significantly. No
effect was found on mortality rates and LOS [38].
Summary and recommendation:
General preoperative medical assessment and optimi-
sation is intuitively important, but for specified risk
assessment tools, the evidence of their clinical accuracy
remains low.
Smoking increases the risk of postoperative complica-
tions. Smoking should cease preoperatively for at least
4 weeks to reduce respiratory and wound-healing compli-
cations; shorter periods may still yield lesser benefits.
Intense counselling and nicotine replacement therapy are
most likely to be effective. Although meta-analyses show
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Table 1 Differences in quality of evidence and recommendation grade between the guidelines published in 2012 and the current guidelines
ERAS item Guidelines 2018 versus 2012
1. Preadmission information, education and counselling The same recommendation grade but stronger quality of evidence (from low
level to moderate)
2. Preoperative optimisation The same recommendation grade and quality of evidence for alcohol and
smoking. ‘‘Medical risk assessment’’ is added in Guidelines 2018
3. Prehabilitation The recommendation grade is currently weak (no recommendation at all in
previous guidelines). Quality of evidence moderate in functional capacity
compare to very low in 2012
4. Preoperative nutritional care Not specified in Guidelines 2012
5. Management of Anaemia Not specified in Guidelines 2012
6. Prevention of nausea and vomiting (PONV) The same recommendation grade on multiple interventions but stronger
quality of evidence (from low to high)
7. Pre-anaesthetic medication The same recommendation grade on avoiding sedatives but weaker quality of
evidence (from high to moderate)
8. Antimicrobial prophylaxis and skin preparation The same recommendation grade and quality of evidence on the use of
intravenous antibiotics. However, a weak recommendation and low-quality
of evidence for the use oral antibiotics in patients without bowel
preparation
9. Bowel Preparation The same recommendation grade and quality of evidence
10. Preoperative fluid and electrolyte therapy Not specified in Guidelines 2012
11. Preoperative fasting and carbohydrate loading The recommendation grade for preoperative carbohydrate drinks is upgraded
from weak to strong and quality of evidence to low from very low
12. Standard Anaesthetic Protocol This part is redesigned since guidelines 2012 and now includes
recommendation grade and quality of evidence for the use of Cerebral
Monitoring and neuromuscular block
13. Intraoperative fluid and electrolyte therapy The strong recommendation on goal-directed fluid therapy (GDFT) in all
patients in 2012 has been modified to include high-risk patients only
14. Preventing intraoperative hypothermia The same recommendation grade and quality of evidence. Prewarming added
15. Surgical access (open and minimally invasive surgery
including laparoscopic, robotic and trans-anal approaches)
The same recommendation grade but stronger quality of evidence (from
low/moderate to high). New surgical techniques added
16. Drainage of the peritoneal cavity and pelvis The same recommendation grade and quality of evidence
17. Nasogastric Intubation The same recommendation grade and quality of evidence
18. Postoperative analgesia This part is redesigned since guidelines 2012 and now includes
recommendation grade and quality of evidence for several analgesic
methods. The recommendation grade for TEA in laparoscopic surgery is
currently weak
19. Thromboprophylaxis Mechanical thromboprophylaxis (well-fitting compression stockings and/or
intermittent pneumatic compression) should no longer be used in 28 days.
Instead only until discharge. The same recommendation grade for
postoperative LMWH in 28 days (for risk patients). The quality of evidence
in duration of treatment is, however, low
20. Postoperative fluid and electrolyte therapy Not specified in Guidelines 2012
21. Urinary drainage The same recommendation grade and quality of evidence
22. Prevention of postoperative ileus There is no longer any evidence or a recommendation for the use of chewing
gum.
23. Postoperative glycaemic control The use stress-reducing elements of ERAS to minimise hyperglycaemia is
upgraded from low to moderate (quality of evidence)
24. Postoperative nutritional care The same recommendation grade and quality of evidence
A new layout is introduced in the current guidelines so that the reader is able to obtain an efficient overview with the graphs and still find more
details on different items in the text. In the current guidelines, recommendations are based on quality of evidence (high, moderate, low) compared
to previous guidelines (high, moderate, low and very low)
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the impact of alcohol abuse on postoperative outcomes,
only 2 small RCTs show a benefit of alcohol cessation on
outcomes.
Quality of evidence:
Medical risk assessment: Low
Smoking: High
Alcohol: Low
Recommendation:
Risk assessment: Strong
Smoking: Strong
Alcohol: Strong
3. Prehabilitation
Poor preoperative physical status has been shown to be a
risk factor for serious postoperative complications and
prolonged disability [39]. The preoperative period may
provide an opportunity to increase the physiologic reserve
in the anticipation of surgery with the intention to improve
outcomes and accelerate recovery. Therefore, preoperative
optimisation or ‘‘prehabilitation’’ can be a compelling
strategy to address modifiable risk factors that impact
cancer treatment outcomes [40].
Prehabilitation is defined as ‘‘A process in the contin-
uum of care that occurs between the time of diagnosis and
the beginning of acute treatment (surgery, chemotherapy,
radiotherapy) and includes physical, nutritional and psy-
chological assessments that establish a baseline functional
level, identify impairments, and provide interventions that
promote physical and psychological health to reduce the
incidence and/or severity of future impairments’’ [41]. The
initial introduction of prehabilitation programmes using
intense exercise showed poor compliance and modest
changes in postoperative functional capacity [42]. A fol-
low-up RCT using multimodal structured prehabilitation
protocols, which included aerobic and resistance exercises
together with protein supplementation and relaxation
strategies, demonstrated a positive impact on preoperative
physiologic reserve with sustained levels of functional
capacity after surgery [43]. In this study, more than 80% of
patients who received the multimodal prehabilitation pro-
gramme returned to baseline values of functional walking
capacity by 8 weeks. In contrast, only 40% of patients who
did not receive prehabilitation returned to baseline values.
With regard to postoperative complications, one RCT
demonstrated a 51% reduction in postoperative medical
complications using a 4-week prehabilitation programme,
thus showing an association between increase in preoper-
ative aerobic capacity and reduction in complications [44].
Summary and recommendation:
Prehabilitation shows promising results in recovery of
functional capacity and may reduce complications after
colorectal surgery. Patients who are less fit may be more
likely to benefit. Further research is required before con-
sidering this as a mandatory item in an ERAS protocol.
Quality of evidence:
Impact of multimodal prehabilitation to increase func-
tional capacity: Moderate
Impact of multimodal prehabilitation on postoperative
clinical outcome: Low
Recommendation: Prehabilitation: Weak
4. Preoperative nutritional care
Preoperative nutritional screening
Preoperative malnutrition has been associated with
increased postoperative morbidity and mortality as well as
poor oncologic outcomes in surgery for gastrointestinal
cancer [45–48]. Preoperative nutritional assessment to
detect overt or subtle malnutrition offers the opportunity to
improve nutritional status and correct specific deficits [28].
There is no consensus on how to assess preoperative
nutritional status accurately [49]. However, nutritional risk
determined using the Nutritional Risk Screening score
(NRS 2002) has been associated with increased risk of
complications [50]. Preoperative serum albumin
1. INFORMATION
2. OPTIMISATION
3. PREHABILITATION
4. NUTRITION
5. ANAEMIA SCREENING
LOW           MODERATE HIGH
QUALITY OF EVIDENCE AND RECOMMENDATIONS
WEAK
STRONG
Fig. 1 Preadmission items
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concentration has been suggested to be a risk factor of
morbidity and mortality in two large studies [51, 52] and
may be considered part of the preoperative nutritional
assessment [53]. Several more comprehensive assessment
tools both subjective and objectives have been proposed.
Poor scores on the Subjective Global Assessment (SGA),
the Patient Generated Subjective Global Assessment (PG-
SGA) and the Malnutrition Universal Screening Tool
(MUST) have been associated with both morbidity and
mortality after major abdominal surgery and have been
considered to be the reference standard for nutritional
screening [54–58].
Preoperative nutrition
The risk of complications is increased in patients with
unintentional weight loss of 5–10% or more [59], and
patients with higher nutritional risk benefit from preoper-
ative nutritional treatment [28]. For malnourished patients,
oral nutritional supplementation (or additional parenteral
nutrition when indicated) has the best effect if started
7–10 days preoperatively and is associated with a reduc-
tion in the prevalence of infectious complications and
anastomotic leaks [60].
Summary and recommendation:
Preoperative routine nutritional assessment offers the
opportunity to correct malnutrition and should be offered.
Preoperatively, patients at risk of malnutrition should
receive nutritional treatment preferably using the oral route
for a period of at least 7–10 days.
Quality of evidence:
Preoperative screening: Low
Preoperative nutrition: Moderate
Recommendation grade:
Preoperative screening: Strong
Preoperative nutrition: Strong
5. Management of Anaemia
The World Health Organisation definition of anaemia is
a haemoglobin (Hb) concentration of\ 130 g/L for men
and\ 120 g/L for women but recently it has been pro-
posed that women should be considered anaemic if Hb\
130 g/L as most attain this figure if not iron deficient
[61, 62]. Twenty-five percentage of women with subnormal
Hb (120 g/L) are iron deficient [63]. This has significant
implications for the potential to restore haemoglobin
rapidly through haemopoiesis after blood loss. Anaemia is
common in patients presenting for surgery. In a large study
with data reported from all surgical specialties showed a
prevalence of 31.1% in men and 26.5% in women [64].
Patients scheduled for surgery may have many factors
causing anaemia: acute or chronic blood loss; vitamin B12
or folate deficiency; anaemia of chronic disease related or
unrelated to their reason for surgery, or a combination of
these [63]. All causes of anaemia should be investigated
appropriately and corrected. Most patients presenting for
colorectal surgery will have iron deficiency because of
blood loss or chronic inflammation [62].
Anaemia—Risks of Complications & Mortality
Anaemia may be a risk factor for all complications and
mortality [64, 65]. However, the administration of blood
products peri-operatively may also increase complications
and have a long-term impact on survival in patients with
colorectal cancer [66]. One retrospective series of 23,388
patients undergoing colorectal surgery showed that 7.9% of
patients received blood transfusions. Statistically, there
was no increase in superficial or deep wound infection but
there was an increase in organ space surgical site infection
and septic shock [67]. In elective orthopaedic surgery,
transfusion of blood products increased 4-year mortality by
10% [65]. In liver resection for metastatic colorectal cancer
blood transfusion is an independent risk for poor short and
long-term outcomes [68, 69]. It is therefore essential to
optimise the patient’s Hb concentration preoperatively. The
time frame to do this will vary according to the indication
and urgency for surgery and how rapidly blood loss is
occurring.
Optimal Perioperative Haemoglobin targets
Significant perioperative blood loss can lead to the
question of whether to transfuse blood products. The
American Society of Anaesthesiologists recommend that a
minimum Hb concentration of 60–100 g/L is maintained
through the perioperative period individualised to a patient
depending on their comorbidities and type of surgery [70].
Patients with, cardiac, renal and pulmonary problems are at
higher risk as haemoglobin declines acutely and in these
groups a target Hb of[ 80 g/L may be better to avoid
complications.
Preoperative Interventions to increase haemoglobin
Anaemia of Chronic Disease
In anaemia of chronic disease, such as that encountered
in inflammatory bowel disease, the iron regulatory protein
hepcidin is activated in response to inflammation. It inhi-
bits absorption of iron from the gastrointestinal tract and
reduces bioavailability of iron stores for red cell production
in the marrow, making oral iron therapy not very effective.
Intravenous iron infusions can overcome this problem in
some instances [63].
Oral Iron Therapy
Oral iron is cheap and administered easily but may be
tolerated poorly. Absorption of iron may be better by using
lower doses between the range of 40–60 mg per day or
alternate day with 80–100 mg [63]. Many colorectal sur-
gical patients will either not respond to oral iron due to
chronic illness or because of ongoing blood loss. Intra-
venous iron infusion may be worth considering in this
group and is discussed below.
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Intravenous Iron Infusions
There are now several different iron infusions available
in clinical practice with a low serious adverse reaction rate
of 38 incidents per million episodes of administration [71].
Acute reactions are normally mediated via complement
activation due to nanoparticles rather than an IgE-mediated
response [72]. Timing of and the number of infusions
depends on the urgency of surgery; 1–1.5 g usually restores
iron stores back to normal and can be given in single or
divided doses. One study reports a mean Hb increase of
8 g/L over 8 days following IV ferric carboxymaltose
15 mg/kg, max 1000 mg, given as a single dose over
15 min [73]. A reticulocytosis occurs at 3–5 days after
administration. The addition of erythropoietin is not rec-
ommended. Timing of infusions and effectiveness in dif-
ferent colorectal populations has still to be determined by
large-scale studies although the preoperative target of
130 g/L should be pursued. Serum ferritin concentra-
tion\ 30 lg/L is the most sensitive and specific test used
for the identification of absolute iron deficiency. However,
in the presence of inflammation (C-reactive pro-
tein[ 5 mg/L) and/or transferrin saturation\ 20%, a
serum ferritin concentration\ 100 lg/L is indicative of
iron deficiency [62].
Summary and recommendation:
Anaemia is common in patients presenting for colorectal
surgery and increases all cause morbidity. Attempts to
correct it should be made prior to surgery. Newer prepa-
rations of intravenous iron have a low risk of adverse
reactions and are more effective than oral iron at restoring
haemoglobin concentrations in both iron deficiency anae-
mia and anaemia of chronic disease. Blood transfusion has
long-term effects and should be avoided if possible.
Quality of evidence: Screening and treatment of anaemia
before surgery: High
Recommendation: Strong
Quality of evidence: Using a restrictive blood transfusion
practice: High
Recommendation: Strong
Preoperative items
See Fig. 2.
6. Prevention of nausea and vomiting (PONV)
The prevention of postoperative nausea and vomiting
(PONV) is fundamental for patients undergoing colorectal
surgery. PONV when severe may result in dehydration,
delayed return of adequate nutrition intake, or may require
the placement of a nasogastric tube, increase intravenous
fluid administration postoperatively, prolong hospital stay,
and increase healthcare costs.
PONV affects 30% (vomiting) to 50% (nausea) of all
surgical patients and up to 80% of patients who are at high
risk for developing these complications [74]. It is also a
leading cause of patient dissatisfaction [75]. The aetiology
of postoperative nausea and vomiting is multifactorial and
is generally divided into patient-related, anaesthesia-related
and surgery-related factors [76]. Female gender, those with
a past history of PONV or motion sickness and non-
smokers, are at particular risk [77]. Volatile anaesthetic
gases, nitrous oxide (both of which can be mitigated in part
by the use of total intravenous anaesthesia (TIVA) with
propofol) and the liberal use of opioids increase the risk
significantly [78]. The type and duration of surgery and the
gastrointestinal pathology are also important. While opioid
use cannot necessarily be avoided, analgesia is best pro-
vided by opioid-sparing multimodal techniques. Some
studies suggest that carbohydrate loading may also reduce
PONV [79].
Several scoring systems have been described for the
prediction of PONV, with simpler ones appearing to pro-
vide better discrimination [80]. The most commonly used
6. PREVENTION OF NAUSEA AND
VOMITING
7. SELECTIVE PREMEDICATION
8. PROPHYLACTIC ANTIBIOTICS
9. NO BOWEL PREPARATION
10. MAINTAINING EUVOLAEMIA
11. NO FASTING AND
CARBOHYDRATE DRINK
LOW                  MODERATE               HIGH
QUALITY OF EVIDENCE AND RECOMMENDATIONS
WEAK
STRONG
Fig. 2 Preoperative items
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are the Koivuranta score and Apfel’s simplification of this
score. These scores are useful when combined with specific
therapeutic interventions, especially in high-risk patients
[81, 82]. An alternative strategy employed in many prac-
tices but not yet studied may be to administer antiemetic
prophylaxis (between one and three medications) to all
patients who are having inhalational anaesthesia, opiates or
major abdominal surgery. This approach is gaining popu-
larity among anaesthetists given that the cost and side-
effect profiles of commonly used antiemetic drugs are
small [83].
There are several classes of first-line antiemetic drugs,
including dopamine (D2) antagonists (e.g. droperidol),
serotonin (5HT3) antagonists (e.g. ondansetron) and cor-
ticosteroids (e.g. dexamethasone). In one study of 5199
patients, when these classes of drugs were given individ-
ually, they were demonstrated to contribute a relative risk
reduction of about 25% [84], while multimodal adminis-
tration of antiemetic drugs reducing PONV even further
[85]. If rescue PONV treatment is required, a different
class of antiemetic should be administered than the one
administered for prophylaxis [74]. For dexamethasone, the
dose administered may vary, but a recent meta-analysis
with 6696 patients showed that a 4–5 mg dose had clinical
effects similar to the 8–10 mg dose [86]. The use of dex-
amethasone for open or laparoscopic bowel surgery was
further confirmed in the recently published Dexamathasone
Reduces Emesis After Major Gastrointestinal Surgery
(DREAMS) Trial in which 1350 patients were studied. A
single 8 mg dose of dexamethasone reduced PONV at 24 h
and reduced the need for rescue antiemetics for up to 72 h,
without an increase in adverse events [87]. However, the
immunosuppressive effects of dexamethasone on long-term
oncological survival are still unknown. Other, second-line
drugs, such as antihistamines (e.g. promethazine), anti-
cholinergics (e.g. scopolamine) and other D2 antagonists
such as metoclopramide may also be used, but their use
may be limited by common side effects such as sedation,
dry mouth, blurred vision and dyskinesia.
More recently, the use of preoperative administration of
gabapentin and pregabalin has been examined for a range
of operations. Recent meta-analyses confirm that both
drugs significantly reduce nausea and vomiting, although
there is a significantly increased risk of visual disturbance
(pregabalin) [88] and sedation (gabapentin and pregabalin)
[89]. A neurokinin-1 (NK1) receptor antagonist (e.g.
aprepitant) may be used in high-risk patients, although it
has not been shown to be superior to ondansetron in PONV
prevention [90].
In addition, the use of prophylactic analgesia such as
intravenous paracetamol (acetaminophen) (i.e. before the
onset of pain) in a meta-analysis of 2364 patients reduced
the incidence of nausea and correlated with the reduction in
pain [91]. There is also some evidence for the use of
alternative therapies to reduce PONV, which include music
therapy, aromatherapy, acupuncture, hypnosis and relax-
ation techniques [92]. Finally, there are also reports of a
small beneficial effect of high-inspired oxygen concentra-
tion on reducing the incidence of nausea [93], although one
meta-analysis show no benefit of the treatment [94].
Summary and recommendation:
A multimodal approach to PONV prophylaxis should be
considered in all patients and incorporated into ERAS
protocols. Patients with 1–2 risk factors should ideally
receive a two-drug combination prophylaxis using first-line
antiemetics. Patients with C 2 risk factors undergoing
colorectal surgery should receive 2–3 antiemetics. If nau-
sea and or vomiting still occur, despite prophylaxis, sal-
vage therapy should be provided using a multimodal
approach using different classes of drugs from those used
for prophylaxis.
Quality of evidence:
Multimodal PONV prophylaxis: High
PONV rescue with different class of antiemetic: High
Recommendation grade: Strong
7. Pre-anaesthetic medication
Psychological distress (pre- and postoperative anxiety)
may increase perioperative analgesic requirements [95] and
postoperative complication rates [96]. Given that high
levels of anxiety occur days prior to hospital admission,
and only in a minority of patients peaks on the day of
surgery, it is imperative that anxiolytic strategies are
employed that exceed the mere administration of anxi-
olytic-sedatives (benzodiazepines) in the immediate pre-
operative period. Effective communication strategies,
including attending a preoperative educational session
(‘Surgery School’) with information for patients on the
intent of ERAS pathways, can successfully reduce patient
anxiety and improve their perioperative experience [18].
The adverse side effects of drugs, such as benzodi-
azepines, opioids or beta-blockers, can limit their use as
anxiolytic pre-anaesthetic medications [97]. In particular,
benzodiazepines, even after single-dose administration,
may cause psychomotor and cognitive impairment and
exhibit sedative effects. The American Geriatrics Society
Beers Criteria for Potentially Inappropriate Medication
(PIM) use in older patient populations (aged 65 years and
older) [98] provide a strong recommendation, with mod-
erate quality of evidence, that due to their increased sen-
sitivity to all benzodiazepines and due to their decreased
metabolism of long-acting agents, that benzodiazepines
should be avoided in older patients where possible to offset
the risk of cognitive impairment, delirium and falls. While
there are data against the use of pre-medication especially
in the elderly, studies from day surgery report minimal
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impact on time to discharge, less nausea and headaches
with the use of lower doses of benzodiazepines. However,
there remains a risk of impaired motor function in higher
doses [99, 100].
Given the disadvantages of benzodiazepines, alternate
anxiolytics should be explored when pre-anaesthetic med-
ication is needed. A meta-analysis, with high-grade quality
of evidence, reported that melatonin (tablets or sublin-
gually) provided effective preoperative anxiolysis with few
side effects compared with placebo; with low-grade quality
of evidence that melatonin is equally effective to midazo-
lam and that melatonin may also provide postoperative
anxiolysis [101].
Pre-anaesthetic medication can also be employed as part
of the ERAS strategy to achieve multimodal, opioid-spar-
ing analgesia to decrease opioid-related adverse effects
(e.g. nausea, vomiting, sedation, ileus and respiratory
depression) and to expedite recovery after surgery. Pre-
anaesthetic medication may therefore include a combina-
tion of paracetamol, a NSAID and a gabapentinoid (such as
gabapentin and pregabalin, originally used for the treat-
ment of chronic neuropathic pain). Paracetamol, NSAIDS
and gabapentinoids administered as oral formulations prior
to surgery are very cost-effective. All should be age and
dose adjusted. It is important that the timing of dosing
should achieve an optimal pharmacodynamic effect that
coincides with the onset of surgery to ensure a maximal
multi-modal opioid-sparing effect.
Gabapentinoids are only available in an oral form and
are increasingly used as oral pre-anaesthetic medications
for their opioid-sparing effects. Meta-analyses indicate that
a single dose of gabapentin or pregabalin, administered
preoperatively, associates with decreased postoperative
pain and opioid consumption; however, these benefits are
offset by increased postoperative sedation, dizziness and
visual disturbances [102, 103]. All doses of pregabalin
(B 75, 100–150 and 300 mg) resulted in an opioid sparing
at 24 h after surgery. Importantly, there were no significant
differences in acute pain outcomes between single preop-
erative dosing regimens and those including additional
doses repeated after surgery [103]. To limit the adverse
effects, including synergistic effects with opioids, sedation,
dizziness and peripheral oedema, gabapentinoid dosing
should be limited to a single and lowest preoperative dose,
unless indicated for postoperative neuropathic pain. In
elderly patients and patients with renal dysfunction the
dose of these agents should be adjusted accordingly and be
used with further caution.
Summary and recommendation:
Preoperative education can reduce patient anxiety to an
acceptable level without the need for anxiolytic medica-
tion. Pharmacologic anxiolysis with long- or short-acting
sedative medication (especially benzodiazepines and
especially in the elderly) should be avoided if possible
before surgery. Opioid-sparing multimodal re-anaesthetic
medication can be used with a combination of acet-
aminophen, NSAIDS and [70] gabapentanoids. All should
be dose adjusted according to age and renal function.
Gabapentinoids should preferably be limited to a single
lowest dose to avoid sedative side effects.
Quality of Evidence:
Avoiding routine sedative medication: Moderate
Recommendation grade: Strong
8. Antimicrobial prophylaxis and skin preparation
A Cochrane review published in 2014 underpinned the
mandatory use of oral or intravenous antibiotic prophylaxis
before colorectal surgery with a consecutive reduction of
surgical site infections (SSI) from 39 to 13% [104]. Stan-
dard oral or intravenous antibiotics covering aerobic and
anaerobic bacteria was the preferred option, with current
preference for a cephalosporin in combination with
metronidazole. Intravenous antibiotic prophylaxis should
be administered within 60 min before incision. No benefit
was shown for repeated administration [104, 105]. These
conclusions are made on studies where patients are treated
with bowel preparation.
Addition of oral antibiotic decontamination to preoper-
ative intravenous antibiotics is an ongoing controversy.
The additional benefits of administering oral antibiotics,
which are usually given 18–24 h before surgery, are
attributed to its possible local effects of inhibiting oppor-
tunistic pathogens in the colonic lumen before opening the
colon, however, with a potential pitfall to disturb the gas-
trointestinal microbiota. The addition of oral antibiotics to
intravenous administration in patients with bowel prepa-
ration was shown to reduce the risk for surgical site
infections when compared with intravenous coverage alone
[RR 0.56 (0.43, 0.74]) or oral alone [RR 0.56 (0.40–0.76)]
[104]. These results were confirmed in a recent meta-
analysis [106] where SSI was significantly reduced in
patients who received oral and systemic antibiotics and
mechanical bowel preparation compared with patients who
received systemic antibiotics alone with mechanical bowel
preparation. Similarly, retrospective registry data from the
USA suggested largely reduced SSI rates in patients having
both, mechanical bowel preparation in combination with
oral antibiotics alone [107]. However, oral antibiotic
decontamination alone in patients with no bowel prepara-
tion has not been studied and any potential effect remains
unknown. Also, it remains unknown if the triple combi-
nation of intravenous antibiotics, oral decontamination and
bowel preparation is superior to only intravenous prophy-
laxis and bowel without preparation.
For skin decontamination, a randomised trial in col-
orectal surgery and a recent meta-analysis of 13 RTCs
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(6997 patients) suggested lower incidence of SSI after
preoperative antisepsis using chlorhexidine [108, 109]. In
contrast, available evidence does not support the practice
of preoperative antiseptic shower or adhesive drapes
[110, 111]. Lastly, routine hair removal before surgery
does not reduce SSI rates, but should be preferably per-
formed—if deemed necessary—by use of clippers rather
than razors immediately before surgery [112].
Summary and recommendation:
Intravenous antibiotic prophylaxis should be given
within 60 min before incision as a single-dose admin-
istration to all patients undergoing colorectal surgery. In
addition, in patients receiving oral mechanical bowel
preparation, oral antibiotics should be given. No recom-
mendation for the use of oral antibiotic decontamination
can be given for patients having no bowel preparation.
Skin disinfection should be performed using chlorhex-
idine–alcohol-based preparations. Evidence is insuffi-
cient to support advanced measures such as antiseptic
showering, routine shaving and adhesive incise sheets.
Quality of evidence:
Intravenous antibiotic prophylaxis: High
Oral antibiotic decontamination: Low
Chlorhexidine–alcohol-based skin preparation: High
Advanced measures for skin decontamination: Low
Patients undergoing resections receiving MBP: Oral and
intravenous prophylaxis: Low
Recommendation grade:
Intravenous antibiotic prophylaxis: Strong
Oral antibiotic decontamination: Weak
Chlorhexidine–alcohol-based skin preparation: Strong
Advanced measures for skin decontamination: Weak
Patients undergoing resections receiving MBP: Oral and
intravenous prophylaxis: Weak
9. Bowel preparation
In previous ERAS guidelines in colon [9] and rectum
[10] surgery, given the universal use of systemic antibiotic
prophylaxis, the recommendation has been to avoid the use
of mechanical bowel preparation (MBP) in colonic surgery
but that it may be advantageous in rectal surgery. The
rationale behind this is to avoid preoperative dehydration,
electrolyte disturbance and discomfort with no clinical gain
for the patient [113].
The role of MPB alone has been evaluated in a meta-
analysis of 36 studies comparing adult patients receiving
MBP versus with those receiving no MBP [114]. A total of
21,568 patients undergoing elective colorectal surgery
were included from 23 RCTs and 13 observational studies.
When all studies were considered, MBP versus no MBP
was not associated with any significant difference in
anastomotic leak rates (OR 0.90, 95% CI 0.74 to 1.10),
surgical site infection (OR 0.99, 95% CI 0.80 to 1.24),
intra-abdominal collection (OR 0.86, 95% CI 0.63 to 1.17),
mortality (OR 0.85, 95% CI 0.57 to 1.27), reoperation (OR
0.91, 95% CI 0.75 to 1.12) or hospital LOS (overall mean
difference 0.11 days, 95% CI - 0.51 to 0.73), when
compared with no MBP, nor when evidence from RCTs
only were analysed. A sub-analysis of MBP versus abso-
lutely no preparation or a single rectal enema similarly
revealed no differences in clinical outcomes. Still, in rectal
surgery, a diverting stoma is often used and this may be a
reason for MBP or an enema to avoid stools remaining in
the diverted colon.
Recently the avoidance of MBP has been questioned
mainly because of data from retrospective cohort and large
database studies from the USA, indicating that the com-
bination of oral antibiotic preparation together with sys-
temic antibiotics and MBP reduces morbidity after
colorectal surgery compared with MBP and systemic
antibiotics alone [115], but also compared with patients
who received no bowel preparation but systemic antibiotics
alone [116]. These findings are also supported by a meta-
analysis of 1769 patients in randomised trials [106]. Much
of these new data have been derived from the American
College of Surgeons National Surgical Quality Improve-
ment Program (ACS NSQIP) targeted colectomy data-
base, with a likely degree of cross-reporting of patient
populations. A recent meta-analysis of 23 randomised
controlled trials and 8 cohort studies [117] including a total
of 63,432 patients undergoing elective colorectal surgery
demonstrated that systemic antibiotic used alone was
associated with a significant reduction in surgical site
infection versus oral antibiotics alone [Odds Ratio (OR)
1.82, 95% CI 1.28 to 2.59], although the combination of
oral and systemic antibiotics was superior to oral antibi-
otics alone (OR 0.44, 95% CI 0.33 to 0.58). The addition of
oral antibiotic preparation to MBP in the setting of sys-
temic antibiotics significantly reduced the incidence of
surgical site infection (RR 0.48, 95% CI 0.44 to 0.52).
However, when studies comparing oral antibiotic prepa-
ration and systemic antibiotic versus MBP and systemic
antibiotic were compared, no significant difference was
seen in the incidence of surgical site infection (RR 0.94,
95% CI 0.73 to 1.20).
The largest observational study to date arising from the
ACS NSQIP database [118] included 40,446 patients, with
13,219 (32.7%), 13,935 (34.5%), and 1572 (3.9%) in the
no-preparation, mechanical bowel preparation alone, and
oral antibiotic preparation alone groups, respectively, and
11,720 (29.0%) in the combined preparation group. Con-
ditional logistic regression following patient matching, oral
antibiotic preparation alone was protective of surgical site
infection (OR, 0.63; 95% CI, 0.45–0.87), anastomotic leak
(OR, 0.60; 95% CI, 0.34–0.97), ileus (OR, 0.79; 95% CI,
0.59–0.98) and major morbidity (OR, 0.73; 95% CI,
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0.55–0.96), but not mortality (OR, 0.32; 95% CI,
0.08–1.18). Combined oral antibiotics and MBP conveyed
no benefit in any major outcome over oral antibiotics alone
in this study. However, to date no RCTs have been per-
formed to support this observation, and as such, further
high-quality evidence is necessary to inform the debate.
Summary and recommendation:
Mechanical bowel preparation alone with systemic
antibiotic prophylaxis has no clinical advantage and
can cause dehydration and discomfort and should not be
used routinely in colonic surgery, but may be used for
rectal surgery. There is some evidence from randomised
controlled trials to support the use of a combination of
MBP and oral antibiotics over MBP alone.
MBP Alone:
Quality of evidence: High
Recommendation grade: Strong
Combined MBP and oral antibiotic preparation:
Quality of evidence: Low
Recommendation grade: Weak
10. Preoperative fluid and electrolyte therapy
It is imperative that the patient should reach the anaes-
thetic room in as close a state to euvolaemia as possible
and any preoperative fluid and electrolyte excesses or
deficits must be corrected. Pre-existing comorbidities must
be taken into account when assessing fluid status. Avoid-
ance of prolonged preoperative fasting, provision of clear
liquids (including carbohydrate drinks) for up to 2 h prior
to the induction of anaesthesia and avoidance of mechan-
ical bowel preparation help reduce the incidence of pre-
operative fluid and electrolyte deficits and substantially
reduced intraoperative fluid requirements. However, when
mechanical bowel preparation is indicated, patients may
lose up to 2 L of total body water as a consequence [113],
and fluid and electrolyte derangements may occur even if
patients are permitted oral fluids. Hence, some of these
patients may require appropriate intravenous fluid therapy
to compensate for these deficits and improve outcome
[119].
Summary and recommendation: Patients should reach
the anaesthetic room in as close a state to euvolaemia as
possible and any preoperative fluid and electrolyte
excesses or deficits should be corrected.
Quality of evidence: Moderate
Recommendation grade: Strong
11. Preoperative fasting and carbohydrate loading
Several RCTs have demonstrated that non-alcoholic
clear fluids can be safely given up to 2 h, and a light meal
up to 6 h, before elective procedures requiring general
anaesthesia, regional anaesthesia or procedural sedation
and analgesia in children and adults [120–122].
Preoperative administration of oral carbohydrates
(complex CHO-maltodextrin, 12.5%, 285 mOsm/kg,
800 ml in the evening before surgery and 400 ml 2–3 h
before induction of anaesthesia) has been shown to atten-
uate the catabolic response induced by overnight fasting
and surgery [123]. CHO in RCTs has been shown to
improve preoperative well-being, reduce postoperative
insulin resistance, decrease protein breakdown and better
maintain lean body mass and muscle strength, as well as
beneficial cardiac effects. In a recent large RCT in 880
patients undergoing elective major abdominal surgery, oral
CHO administration resulted in lower insulin requirements
and less hyperglycaemia ([ 180 mg/dl) compared with
placebo [124]. Another recent RCT in coronary artery
bypass patients, reported that CHO significantly reduced
myocardial injury [125].
Faster surgical recovery and better postoperative well-
being from CHO still remains controversial, while few data
so far support an effect on postoperative morbidity or
mortality from this treatment. In a recent Cochrane
Review, 27 trials involving 1976 participants were inclu-
ded [126]. Trials were performed in Europe, China, Brazil,
Canada and New Zealand and involved patients undergo-
ing elective minor and major abdominal surgery, ortho-
paedic surgery, cardiac surgery and thyroidectomy.
Overall, the administration of preoperative carbohydrate
was associated with a small reduction in hospital stay (MD
- 0.30 days, 95% CI - 0.56 to - 0.04) compared with the
placebo or fasting group. Patients undergoing major
abdominal surgery had a greater absolute decrease in LOS
(MD - 1.66 days, 95% CI - 2.97 to - 0.34). However,
the heterogeneity observed in average LOS, and the vari-
ation in study quality makes the interpretation of these
results difficult.
Based on two trials including 86 participants, preoper-
ative carbohydrate treatment was also, in this review,
associated with shortened time to passage of flatus when
compared with placebo or fasting, as well as increased
postoperative peripheral insulin sensitivity.
Oral fluids including CHOs may not be administered
safely in patients with documented delayed gastric emp-
tying or gastrointestinal motility disorders as well as in
patients undergoing emergency surgery. Although gastric
emptying has been reported previously to be normal in
obese patients [127], diabetics when given with their nor-
mal diabetic medication [128], and elderly patients with
acute hip fracture [129], studies are still too small and
incomplete to allow routine to recommendation of this
intervention in such patients. However, both obese and
diabetic patients have been increasingly included in recent
studies of CHO [130] and no issues with regard to safety
have been reported.
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Summary and recommendation:
Patients undergoing elective colorectal surgery should
be allowed to eat up until 6 h and take clear fluids
including CHO drinks, up until 2 h before initiation of
anaesthesia. Patients with delayed gastric emptying and
emergency patients should remain fasted overnight or
6 h before surgery. No recommendation can be given for
the use of CHO in patients with diabetes.
Quality of evidence:
In elective colorectal surgery in patients without delayed
gastric emptying; 6-h fasting for solids and 2 h for clear
fluids including CHO drinks: High
CHO drinks improving well-being, insulin resistance:
Moderate
CHO drinks reducing complications and improving
recovery time: Low
Recommendation grade: Adherence to fasting guidelines
(avoid overnight fasting): Strong
Administration of preoperative CHOs: Strong
Administration of preoperative CHOs in well-controlled
diabetic and obese patients: weak
Intraoperative items
See Fig. 3.
12. Standard Anaesthetic Protocol
Anaesthetic agent and Cerebral Function Monitoring
The avoidance of benzodiazepines and use of short-
acting general anaesthetic agents in an opioid-sparing
ERAS Pathway allow rapid awakening with minimal
residual effects. Propofol for induction of anaesthesia,
combined with short-acting opioids such as fentanyl,
alfentanil, sufentanil or remifentanil infusions, if opioids
are required, minimises residual effects at the end of
anaesthesia. There are no strong data to support the rec-
ommendation of either anaesthetic gases or total intra-
venous anaesthesia (TIVA) using propofol infusions to
maintain anaesthesia. The use of propofol TIVA may
reduce PONV in certain patients and there are data from a
large retrospective study suggesting a beneficial effect of
propofol on cancer outcomes, but no definitive recom-
mendation can be made for this currently [131]. In intu-
bated patients under general anaesthesia, using short-acting
inhalational agents such as sevoflurane or desflurane in
oxygen-enriched air is standard practice around much of
the world [132]. Nitrous oxide is normally avoided due to
its delaying effects on the bowel although the increased
risk of PONV can be markedly reduced with standard
PONV prophylaxis [133].
Cerebral Function Monitoring using bi-spectral index
(BIS) and maintaining a target between 40 and 60 can
reduce the risk of awareness in high-risk patients [134].
The use of BIS or newer burst suppression monitoring to
avoid overdose of anaesthesia in the elderly may have a
role in reducing the risk of postoperative delirium and
postoperative cognitive dysfunction in this patient popu-
lation [135].
Muscle relaxation and Neuromuscular Monitoring
Laparoscopic and robotic surgery requires insufflation
of the peritoneum to create space for operating. High intra-
abdominal pressure can worsen cardiac function, impede
ventilation and reduce renal blood flow [136]. There is
some evidence in certain patients suggesting that main-
taining muscle relaxation of the abdominal muscles (a term
called ‘deep block’) may allow operating at lower pressure
while maintaining intra-abdominal space for surgery [137].
Reducing the intra-abdominal pressure below
10–12 mmHg may result in a reduction in the physiologi-
cal effects of pneumoperitoneum leading to a reduction in
aortic afterload, improvement in renal blood flow and
lower peak airway ventilator pressures [138].
There is evidence to support that cumulative dosing of
intermediate muscle relaxants increases the risk of post-
operative pulmonary complications [139]. Neuromuscular
monitoring should be a standard of care with
12. STANDARD ANAESTHETIC
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Fig. 3 Intraoperative items
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acceleromyography (objective monitoring) being more
accurate than basic peripheral nerve stimulators. Reversal
of neuromuscular block to a train-of-four (TOF) ratio of
90% is important to avoid residual paralysis and risk of
postoperative pulmonary complications [140]. Sugam-
madex reverses rocuronium and vecuronium rapidly and
predictably by encapsulating the molecules responsible for
paralysis. Neostigmine is an alternative option for reversal
due to its anticholinergic effect. If correctly dosed, sug-
ammadex reduces the risk of residual neuromuscular block
[141].
Summary and recommendation:
The use of short-acting anaesthetics, cerebral monitoring
to improve recovery and reduce the risk for postoper-
ative delirium, monitoring of the level and complete
reversal of neuromuscular block is recommended.
Quality of evidence: Short-acting anaesthetics: Low
Recommendation grade: High
Quality of evidence: Use of Cerebral Monitoring: High
Recommendation grade: Strong
Quality of evidence: Reducing intra-abdominal pressure
during laparoscopic surgery facilitated by neuromuscular
block: Low
Recommendation grade: Weak
Evidence: Monitoring (objective) the level and complete
reversal of neuromuscular block: High
Recommendation grade: Strong
13. Intraoperative fluid and electrolyte therapy
The aim of intravenous fluid therapy is to maintain
intravascular volume, cardiac output and tissue perfusion
while avoiding salt and water overload. Most patients
require crystalloids at a rate of 1–4 ml/kg/h to maintain
homoeostasis [142]. However, some patients require vol-
ume therapy where goal-directed boluses of intravenous
solutions (usually a colloid) aimed at maintaining central
normovolaemia by utilising changes in stroke volume
measured by a minimally invasive cardiac output monitor
to optimise the patients on their individual Frank–Starling
curve [143, 144]. Fluids are administered to treat objective
evidence of hypovolaemia, and consequently improve
intravascular volume and circulatory flow [145]. Although
the earlier studies on goal-directed fluid therapy (GDFT)
showed a significant improvement in outcome in terms of
reduction in complications, shorter duration of ileus and
reduced LOS, more recent studies performed within the
context of enhanced recovery programmes showed no
difference in outcome [146–148]. Using this concept of
GDFT in the setting or conventional care versus enhanced
recovery protocols, a recent meta-analysis that included 23
studies with 2099 patients has generated interesting results
[149]. Overall, GDFT was associated with a significant
reduction in morbidity, LOS, intensive care LOS and time
to passage of faeces. However, no difference was seen in
mortality, return of flatus or risk of paralytic ileus. If
patients were managed within enhanced recovery path-
ways, the only significant reductions were in intensive care
LOS and time to passage of faeces. If managed in a tra-
ditional care setting, a significant reduction was seen in
both overall morbidity and total hospital LOS. Hence,
within ERAS programmes, it may not be necessary to offer
all patients GDFT, and this should be reserved, after risk
stratification, for high-risk patients or for patients under-
going high-risk procedures [142]. Arterial hypotension
should be treated with vasopressors when administering
intravenous fluid boluses fails to improve the stroke vol-
ume significantly (stroke volume[ 10%) [150, 151]. Ino-
tropes should be considered in patients with reduced
contractility (cardiac index\ 2.5 L/min) to achieve ade-
quate oxygen delivery [151].
Summary and recommendation: The goal of periopera-
tive fluid therapy is to maintain fluid homoeostasis
avoiding fluid excess and organ hypoperfusion. Fluid
excess leading to perioperative weight gain more than
2.5 kg should be avoided, and a perioperative near-zero
fluid balance approach should be preferred. GDFT
should be adopted especially in high-risk patients and
in patients undergoing surgery with large intravascular
fluid loss (blood loss and protein/fluid shift). Inotropes
should be considered in patients with poor contractility
(CI\ 2.5 L/min).
Quality of evidence:
Perioperative near-zero fluid balance: High
GDFT: High
Recommendation grade:
GDFT: Strong in high-risk patients and for patients
undergoing surgery with large intravascular fluid loss
(blood loss and protein/fluid shift)
GDFT: Weak in low-risk patients and in patients
undergoing low-risk surgery
Zero fluid balance: Strong
Use of advanced haemodynamic monitoring: strong in
high-risk patients and for patients undergoing surgery
with large intravascular fluid loss (blood loss and
protein/fluid shift)
14. Preventing intraoperative hypothermia
The importance of maintaining normothermia in patients
(a temperature of 36 C or over) undergoing major surgery
including colorectal surgery is well recognised [152]. Both
general anaesthesia and neuroaxial anaesthesia affect
thermoregulation by impairing vasoconstriction and shiv-
ering, causing temperature redistribution from the core to
the periphery, leading to heat loss in excess of heat pro-
duction [153]. Even mild inadvertent perioperative
hypothermia (IPH) has been associated with adverse
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effects: in a meta-analysis with a median temperature of
35.6 C, blood loss was increased by 16% and blood
transfusion rate by 22% [154]. Other effects may include
vasoconstriction, increased afterload, myocardial ischae-
mia and cardiac arrhythmias, reduction in splanchnic blood
flow and reduced drug biotransformation. The problems
extend well into the postoperative period too, where there
may be shivering with a concomitant increase in oxygen
consumption, a prolonged stay in the post-anaesthetic care
unit (PACU), an increase in rates of infection and a pro-
longed hospital stay. Patients at higher risk of IPH or its
sequalae include ASA 2-5, preoperative hypothermia, those
undergoing combined regional and general anaesthesia,
major surgery and those at risk of cardiovascular compli-
cations [155].
Accurate measurement of temperature is fundamental.
Core temperature measurements are best carried out
directly (or using a direct estimate) rather than using
indirect estimate. Various methods are used such as
nasopharyngeal measurement (with the probe inserted
10–20 cm) [153]. More recently the zero heat-flux (deep
forehead) thermometry is also recommended [155] and has
been the subject of a separate recent review, with over 500
patients from 7 studies confirming its reliability [156].
There are many methods described to conserve body
temperature, including warming and humidification of
anaesthetic gases, warming IV and irrigation fluids and
forced air warming blankets and devices. In addition, the
ambient temperature should be at least 21 C while the
patient is exposed prior to active warming starting [155].
While heat loss in laparoscopic surgery is reduced when
compared with open surgery, hypothermia may still occur
due to cold, dry carbon dioxide used for insufflation. A
recent meta-analysis analysed 13 studies and demonstrated
that the use of warmed and humidified CO2 was associated
with a significant increase in intraoperative core tempera-
ture (mean change 0.3 C) [157]. However, a Cochrane
review looked at 22 studies with 1428 participants, and
while confirming the above preservation of temperature
and demonstrating a reduced post-anaesthesia care unit
(PACU) stay, commented that the data were heterogeneous
and when low risk of bias studies only were included, the
PACU stay was not significantly reduced. Overall there
was no improvement in patient outcome, reduction in lens
fogging, etc., and thus its use was not supported [158].
Another area to minimise IPH is the use of prewarming.
Recent reviews supported this with significantly higher
temperatures perioperatively [159, 160] unless this would
delay emergency surgery, although the practicalities of this
may not be easy to overcome.
Summary and recommendation: Reliable temperature
monitoring should be undertaken in all colorectal
surgical patients and methods to actively warm patients
to avoid IPH should be employed.
Quality of evidence:
Maintenance of normothermia: High
Monitoring of temperature: High
Prewarming: Moderate
Recommendation grade: Strong
15. Surgical access (Open and minimally invasive
surgery including laparoscopic, robotic and trans-anal
approaches)
Minimally invasive surgery (MIS) for both colonic and
rectal resection is well established and in many countries, it
has become the standard of care. The extent to which it has
replaced open surgery varies widely but in European
countries where data collection is good such as Denmark
(Danish colorectal cancer group 2016) and Holland [161]
the reported proportion of colonic and rectal cancer surgery
undertaken with minimally invasive techniques is as high
as 90% with conversion rates of \ 10%. Some countries
have achieved this through centralisation of services and
others such as the UK have undertaken formalised centrally
funded training programmes aimed at safely introducing
new technologies while avoiding a rise in complications
related to the learning curve [162].
There have been several RCTs [163–169] of laparo-
scopic versus open surgery for colorectal cancer, which
generally reveal an advantage in favour of laparoscopy for
recovery, LOS, blood loss and complications. There is
variable evidence of an oncological advantage but no
evidence of an oncological disadvantage. Improved sur-
vival after laparoscopic surgery has been demonstrated in
two trials [168, 169] and a large national audit [170].
Cochrane reviews of the available data concerning short
and long-term outcomes also support the results of the
trials [171–173]. There is no evidence of a difference in
survival comparing laparoscopic and robotic surgery [174],
but data on long-term survival in robotic surgery are still
sparse.
There have been two more recent non-inferiority trials
published [175, 176] of laparoscopic versus open surgery
for rectal cancer that use similar methodologies and use a
composite score of specimen quality as the primary out-
come. Non-inferiority of laparoscopic approach was not
established in either trial but no long-term oncological
results are yet available.
For colonic resection, the options are predominantly
standard laparoscopy with no evidence, introducing robotic
technology adds any advantage but increases costs con-
siderably [177]. Variations such as single-port surgery also
offers little advantage over multiport or reduced port sur-
gery but is practiced effectively by some clinicians who
report better cosmesis and reduced postoperative pain
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[178] although the evidence for this is weak. In both colon
and rectal surgery, hand-assisted laparoscopy has been of
historical interest but is not necessary in modern surgery.
For rectal resection, robotic surgery and laparoscopy
combined with a trans-anal approach to the rectum [179]
have developed as alternatives to standard laparoscopy.
Robotic surgery for rectal cancer has been subjected to a
meta-analysis and a RCT. The meta-analysis [180] showed
no significant difference in any outcomes measure com-
pared with standard laparoscopy except conversion rate.
An RCT showed no significant difference in the primary
outcome measure of conversion and the trial has also
confirmed higher cost and that robotic rectal resection was
not cost-effective [181]. Several systematic reviews of the
trans-anal approach to rectal cancer [182–185] reveal no
difference in specimen quality or anastomotic leak rates
compared with laparoscopic and open surgery. A large
prospective registry of cases has revealed anastomotic
failure rates and specimen quality not dissimilar to data-
bases of standard laparoscopy [186]. An RCT comparing
the trans-anal with standard laparoscopic approach
(COLOR III) has been initiated [187].
The focus on the different minimally invasive approa-
ches is on improving the cancer-related outcomes, reducing
the morbidity of pelvic surgery and reducing conversion
rates. However, all have a similar capacity to reduce the
trauma and immunological impact of surgery compared
with an open approach. MIS is both an important enabling
technology for many of the elements of ERAS and an
independent predictor of good outcome [188]. It indepen-
dently has the capacity to reduce complications, which is
the ultimate goal of an ERAS programme. MIS enables
reduced pain and opiate requirement, early mobilisation,
less impact on fluid shifts and reduced ileus.
The relative influences of laparoscopy and enhanced
recovery protocols have been compared in several trials
[189–191]. The LAFA study [191] was a multicentre RCT,
which randomised patients to laparoscopic and open seg-
mental colectomy and ‘fast track’ and ‘standard care’
within nine Dutch centres. The median hospital stay was
2 days shorter after laparoscopic resection and the best
outcomes with the least impact on the immune system was
in the group receiving both minimally invasive surgery and
enhanced recovery protocol. Regression analysis showed
that laparoscopic surgery was the only predictive factor to
reduce hospital stay and morbidity. The EnRol trial [190]
randomised between laparoscopic and open colorectal
resection within an enhanced recovery protocol and mea-
sured physical fatigue at 1 month as its primary outcome.
Median hospital stay was 2 days shorter after laparoscopic
surgery. A meta-analysis of protocol-driven care and
laparoscopic surgery for colorectal cancer concluded that
the combination reduced colorectal cancer surgery com-
plications, but not mortality [192].
Summary and recommendation:
A minimally invasive approach to colon and rectal
cancer has clear advantages for improved and more rapid
recovery, reduced general complications, reduced
wound-related complications including incisional hernia
and fewer adhesions. It is also an enabler for successful
administration of many of the major components of
ERAS such as opiate sparing analgesia and optimised
fluid therapy.
Quality of evidence:
Minimally invasive surgery versus open surgery: High
Recommendation grade:
Minimally invasive surgery versus open surgery: Strong
16. Drainage of the peritoneal cavity and pelvis
The use of a drain in the pelvic cavity after rectal sur-
gery or the peritoneal cavity after rectal or colonic surgery
has historically been advocated to evacuate or prevent
blood or serous collections and to prevent or detect anas-
tomotic leakage.
In 2004, a Cochrane systematic review compared the
safety and effectiveness of routine drainage after elective
colorectal surgery. The primary outcome was clinically
anastomotic leakage [193] and included 6 RCTs enrolling
1140 patients, but only 2 RCTs (191 patients) separated
low rectal anastomoses. The authors could not find a sig-
nificant difference in outcomes. In 2005, a meta-analysis of
pelvic drains in rectal surgery [194] including three RCTs
reported no effect on anastomotic leakage rate or overall
outcome. A more recent systematic review and meta-
analysis of 11 RCTs with 1803 patients concluded that
pelvic and peritoneal drains did not decrease anastomotic
leakage (clinical or radiological), mortality, wound infec-
tion, nor reoperation rates [195]. Lastly, a recently pub-
lished RCT [196], including 469 patients, showed that the
use of a pelvic drain after rectal surgery for rectal cancer
conferred no benefit to the patient.
Summary and recommendation:
Pelvic and peritoneal drains show no effect on clinical
outcome and should not be used routinely.
Evidence level: High
Recommendation grade: Strong
Postoperative items
See Fig. 4.
17. Nasogastric Intubation
Nasogastric tubes have been in use with the aim of
reducing postoperative discomfort from gastric distention
and vomiting. However, all recent data show that the
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routine use of a NG tube has no positive, but rather a series
of negative effects.
A recent meta-analysis of RCTs including 1416 patients
undergoing colorectal surgery showed that pharyngo-
laryngitis and respiratory infections occurred less fre-
quently if postoperative nasogastric decompression was
avoided but that vomiting was more common [197].
A Cochrane meta-analysis of 33 trials with[ 5000 patients
undergoing abdominal surgery confirmed significant dif-
ferences by an earlier return of bowel function and a
decrease in pulmonary complications if a nasogastric tube
was avoided [198]. A Dutch study with[ 2000 patients
found that the use of nasogastric decompression after
elective colonic surgery declined from 88 to 10% without
increases in patient morbidity or mortality [199]. In an
RCT, patients not receiving nasogastric tubes tolerated oral
intake earlier suggesting that routine nasogastric decom-
pression may unnecessarily delay important nutrition in the
postoperative period [200, 201]. A meta-analysis com-
prising seven recent RCTs (587 patients) comparing the
outcomes following early oral feeding versus traditional
oral feeding with gastric decompression by tube found that
early oral feeding reduced hospital LOS and total of
postoperative complications significantly; there were no
significant differences in anastomotic dehiscence, pneu-
monia, wound infections, rate of nasogastric tube reinser-
tion, vomiting or mortality [202].
The routine insertion of a nasogastric tube during elec-
tive colorectal surgery should be avoided except for
evacuating air that may have entered the stomach during
ventilation by the facial mask prior to endotracheal intu-
bation. An orogastric tube will suffice for this purpose and
is recommended in laparoscopic cases to prevent inadver-
tent gastric injury. If placed during surgery, nasogastric
tubes should be removed before the reversal of anaesthesia.
There is still a roll for inserting an NG tube in patients with
postoperative ileus refractory to conservative management
to decompress the stomach and reduce the risk of
aspiration.
Summary and recommendation:
Postoperative nasogastric tubes should not be used
routinely; if inserted during surgery, they should be
removed before reversal of anaesthesia.
Quality of evidence: High
Recommendation grade: Strong
18. Postoperative analgesia
Postoperative analgesia resulting in adequate pain con-
trol is essential in enhanced recovery pathways in col-
orectal surgery [9, 10, 200, 203, 204]. Although colon and
rectal surgery (open and laparoscopic) differ considerably
regarding technique, surgical trauma and early outcome,
opioid avoiding or sparing techniques in both types of
surgery are associated with early mobilisation, fast return
of bowel function, fewer complications and a reduction in
LOS [9, 10, 200, 203, 204]. Therefore, the key is to avoid
opioids and apply multimodal analgesia in combination
with epidural analgesia (in open surgery) when indicated.
In fact, this multimodal strategy should ideally be included
in the intraoperative period already and be a continuum
postoperatively [9, 10, 200, 204].
Multimodal analgesia
The benefit of using a multimodal approach to pain
management is based on the concept that several multiple
pain reducing mechanisms will improve pain control while
avoiding the side effects of each drug. Paracetamol is a
basic part of this strategy and can be administered easily
[203]. NSAIDS are also vital and key opioid-sparing
component in multimodal analgesia. However, there is still
debate whether NSAIDs are associated with an increased
incidence of anastomotic leakage, but literature shows
inconclusive evidence to avoid NSAIDs in colorectal
17. NO GASTRIC DRAINAGE
18. MULTIMODAL ANALGESIA
19. TROMBOPROPHYLAXIS
20. FLUID NORMOVOLAEMIA
21. URINARY CATH 1-3 D
22. PREVENT HYPERGLYCAEMIA
23. POSTOPERATIVE NUTRITION
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Fig. 4 Postoperative items
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surgery patients other than the regular contraindications
[4, 205]. COX 2 drugs that do not effect platelet aggre-
gation can be used if surgeons are concerned for bleeding.
Several studies investigated opioid-sparing techniques with
systemic additives like lidocaine infusions, a2-agonists like
dexmedetomidine, ketamine, magnesium sulphate, high
dose steroids or gabapentinoids [9, 10, 200, 206–210].
Lidocaine and dexmedetomidine infusions do appear to
reduce postoperative pain in colorectal surgery compared
with placebo [207, 209, 210]. However, there are limited
studies that have systematically assessed the combination
of these systemic additives on adverse events, outcomes
and the analgesic effects compared with other techniques
or in combination with epidural analgesia and TAP blocks
(discussed item 18d) [200]. In both colon and rectal sur-
gery, the use of other additives seems to have promising
pain relieving potential, but needs to be investigated more
extensively regarding efficacy and safety. However, mul-
timodal analgesia is the backbone to reduce opioids in both
open and laparoscopic colorectal surgery. Surgical site
infiltration or more specific port-site local infiltration with
local anaesthetics does appear to reduce postoperative pain
compared with placebo, but limited data are available
[211].
Summary and recommendation: Avoid opioids and
apply multimodal analgesia in combination with
spinal/epidural analgesia or TAP blocks when indicated
Quality of evidence: Moderate
Recommendation grade: multimodal opioid-sparing
analgesia: Strong
18 a Epidural blockade
Metabolic effects
It is well established that epidural blockade with local
anaesthetics, initiated before and continued during and
after surgery, is a successful modality to minimise the
neuro-endocrine and catabolic response to surgery [212].
As one result, insulin resistance, an expression of surgical
stress, is attenuated [213]. Epidural blockade has also
shown to minimise postoperative protein breakdown [214].
This effect is particularly useful when patients are fed in
the immediate postoperative period as postoperative
nitrogen balance is normalised and protein synthesis
facilitated [215, 216]. Current data on metabolic effects
have been mainly shown for open surgery and data for
laparoscopic surgery are yet to be found.
Analgesic outcomes
Thoracic epidural analgesia (TEA) (T7-T10) remains
the gold standard in patients undergoing open colorectal
surgery. Several RCTs and meta-analysis have demon-
strated superior analgesia compared with patients receiving
systemic opioids [217, 218]. Supplementary analgesia is
required in patients undergoing abdominal perineal
resection, in which perineal pain (S1–S3 dermatomes) is
not controlled by TEA. Lumbar epidural blockade is dis-
couraged because of insufficient upper sensory block
covering the surgical incision, lack of blockade of sym-
pathetic fibres and risk of lower limb motor block and
urinary retention [212].
The same analgesic benefits have not been demonstrated
in patients undergoing laparoscopic colorectal surgery
[219] and epidurals may even increase LOS in patients
undergoing minimally invasive surgery. In fact, alternative
co-analgesic techniques, such as intravenous lidocaine
[210, 220–222], spinal analgesia [223–227], abdominal
trunk blocks (ultrasound guided or under direct laparo-
scopic guidance), intraperitoneal local anaesthetic
[228, 229] or continuous wound infusion of local anaes-
thetics [230–232] have shown to provide adequate anal-
gesia, similar to those obtained with TEA [233], but
superior to those provided by systemic opioids alone. TEA
might still be valuable in patients with chronic pain or in
patients in whom the risk of conversion to laparotomy is
high. The results of an RCT comparing TEA with intra-
venous lidocaine in patients undergoing laparoscopic col-
orectal surgery demonstrated that TEA might still be
advantageous in the first 48 h after rectal surgery, as rectal
extraction and anastomosis was performed through a
8–10 cm Pfannenstiel incision [234]. Awareness of the
type of laparoscopic approach used can assist physicians to
decide whether TEA can still be valuable in patients
undergoing laparoscopic colorectal surgery.
A continuous epidural infusion of a mixture of local
anaesthetic and lipophilic opioids provides better analgesia
than local anaesthetic or opioids alone [217, 218, 235]. The
addition of adjuvants such as clonidine [236, 237] or epi-
nephrine (1.5–5 lg/ml) [238, 239] can also be added to
improve segmental analgesia and reduce certain opioids
side effects. A mixture containing local anaesthetic with
epidural morphine instead of lipophilic opioids can provide
better analgesia in patients with long midline incision.
Because of its pre-emptive analgesic effect [240], TEA
should be initiated before surgery and continued in the
intraoperative and postoperative period, for 48–72 h. A
disadvantage of the use of TEA is the primary epidural
failure rates that continue to remain high in some reports
(ranging between 22 and 32%). Additional methods to
correctly identify the epidural space (i.e. epidural stimu-
lation or wave form analysis) and increase the success rate
of epidural blocks can be employed [241, 242]. Appro-
priate postoperative support such as a pain team is also
important to troubleshoot analgesia issues related to TEA
to improve efficacy.
Postoperative non-analgesic outcomes
Despite the results of the largest multicenter RCT
assessing the impact of combining TEA with general
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anaesthesia on 30-day morbidity or mortality in high-risk
patients after major open gastrointestinal surgery did not
show any benefit [237], several subsequent meta-analyses
have shown that TEA accelerates the recovery of bowel
function after colorectal surgery [243–245] and reduces the
risk of respiratory [245, 246] and cardiovascular compli-
cations [245]. There is, however, a higher risk of postop-
erative arterial hypotension and urinary retention [245]. It
must be also acknowledged that the positive impact of TEA
on postoperative morbidity originates from studies in open
surgery with no context of an ERAS program. A recent
meta-analysis including 5 RCTs of patients undergoing
laparoscopic colorectal surgery and all treated with an
ERAS programme does not demonstrate the same benefits
[247]. Some recent evidence also demonstrates that TEA
has no impact [248] or even delays [219, 247, 249] hospital
discharge in patients undergoing laparoscopic colorectal
surgery. This delay might be due to a higher incidence of
hypotension, urinary retention or motor blockade requiring
additional postoperative care [219, 250]. The impact of
TEA on colorectal cancer recurrence and metastasis
[251, 252] remains to be investigated further, especially in
the context of an ERAS program.
Summary and recommendation:
TEA using low dose of local anaesthetic and opioids is
recommended in open colorectal surgery to minimise the
metabolic stress response and provide analgesia postop-
eratively. In patients undergoing laparoscopic surgery,
TEA can be used, but cannot be recommended over
several alternative choices.
To attenuate the neuro-endocrinal stress response:
Quality of Evidence: Laparotomy: High
Recommendation: Strong
Quality of Evidence: Laparoscopy: Low
Recommendation: weak
To provide optimal analgesia
Quality of Evidence: Laparotomy: High
Recommendation: strong
Quality of Evidence: Laparoscopy: Moderate, for not
using it
Recommendation: strong for not using it.
Low-dose local anaesthetic and opioids:
Quality of Evidence: Moderate
Recommendation: Strong
To improve postoperative non-analgesic outcomes
Quality of Evidence: Recovery of bowel function: High,
for using it
Morbidity and mortality: moderate, for using it
Length of hospital stay: high, for not using it (la-
paroscopy, within an ERAS program)
Recommendations: Strong
18 b Spinal Anaesthesia/Analgesia (as an adjunct for
general anaesthesia) for laparoscopic Colorectal
Surgery
Spinal anaesthesia has a high efficacy and relatively low
complication profile [253]. It has been used to facilitate
ultra-rapid recovery after laparoscopic colorectal surgery
by minimising opioid consumption within an ERAS pro-
tocol [226]. As compared with epidural anaesthesia, the
patient can be mobilised sooner and is at less risk of
hypotension and fluid overload that is a risk due to the
sympathetic block induced by continuous thoracic epidural
analgesia [219]. A combination of local anaesthetic such as
bupivacaine 0.5% and long-acting opioid (such as
diamorphine or morphine) is usually used with the total
volume dosing in the range of \ 2.0 ml to avoid high
spinal block. In addition to the local anaesthetic effect,
spinals have been shown to reduce the endocrine-metabolic
stress response but only for the duration of action of the
local anaesthetic where after it returns to levels of controls
[223]. The addition of a long-acting opioid has the benefit
of reducing morphine requirements postoperatively by up
to sixfold with the ability to mobilise patients very soon
after surgery once the motor block has worn off [225]. In
another study, although early recovery was superior there
was no benefit on LOS compared with intravenous mor-
phine alone [227]. The main concern of using intrathecal
opioids is that of delayed respiratory depression. Com-
monly used doses are at the lower end of clinical practice:
300–500 mcg of diamorphine or 100–150 lg of preserva-
tive free morphine. Similar monitoring should be used as if
the patient was using a patient-controlled analgesia pump.
Summary and recommendation:
Spinal anaesthesia with low-dose opioids gives good
analgesic effects, has a transient stress-reducing effect,
and allows postoperative opiate sparing and is recom-
mended as an adjunct option to general anaesthesia in
laparoscopic surgery.
Quality of evidence: moderate
Recommendation: strong
18 c Lidocaine Infusions
The use of lidocaine infusions to reduce opioid use and
nausea in colorectal surgery is now well established [210].
Published dosing ranges from 1.5 to 3 mg/kg/h depending
on the bolus given (0 to 1.5 mg/kg) [254, 255]. Plasma
lidocaine concentrations achieved are similar to those when
running an epidural infusion (approximately 1 lM). Toxi-
city is related to the plasma concentration and appears to be
rare, but monitoring in the postoperative period is impor-
tant [256]. Continuous ECG monitoring is advised and
nurses should be aware of symptoms of local anaesthetic
toxicity such as tinnitus, blurred vision, dizziness, tongue
paraesthesia and perioral tingling.
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The analgesia benefit is in both open surgery and
laparoscopic colorectal surgery. This beneficial effect
appears to last longer than the infusion itself. Studies have
been inconsistent in the duration of use of the infusion with
some stopping at the end of surgery while others continue
between 12 and 24 h postoperatively [254–256].
The incidence of postoperative ileus, which is a major
cause of delayed hospital discharge in colorectal patients,
is reduced in some studies. It is currently unclear whether
this is due to the reduction in opiates or if there are other
direct beneficial actions on the bowel or an anti-inflam-
matory effect [254].
Summary and recommendation:
Lidocaine infusions can reduce opiate consumption after
surgery, whether the treatment reduces the risk of
postoperative ileus remains unclear.
Quality of evidence: Use of lidocaine infusions to reduce
opiate consumption after surgery: High
Recommendation: Strong
18 d Abdominal Wall Blocks
The role of epidural analgesia within the setting of an
enhanced recovery programme has been questioned,
especially with regard to laparoscopic operations
[219, 257]. Interest in local anaesthetic abdominal walls
blocks, as a component of multimodal analgesia, has thus
increased.
Transversus abdominis plane (TAP) blocks are the most
widely studied. Since the initial description, in 2001 [258],
as the classic landmark-based technique, multiple varia-
tions have been described, including 2-point, 4-point,
ultrasound-guided and laparoscopic-visualised blocks. TAP
blocks provide analgesic coverage to the anterior abdomi-
nal wall from T10 to L1 [259] and have been demonstrated
to provide an opioid-sparing approach in colorectal surgery
[260]. As TAP blocks only provide analgesia reliably
below the umbilicus, subcostal and rectus blocks are
adjuncts, which can cover the upper abdomen.
An early Cochrane review of transversus abdominis
plane (TAP) blocks found 5 heterogeneous studies, no
comparisons with other methods of analgesia, and limited
evidence of reduced opioid use [261]. A review of studies
up to early 2016 of peripheral nerve blocks again demon-
strated a lack of data [211]. There have been more recent
RCTs indicating the benefits of TAP blocks in abdominal
surgery in multiple specialties including gynaecologic,
general, bariatric and transplant surgery [262–266] and also
specifically in colorectal surgery with less opioid use, faster
resumption of GI tract function and recovery [267, 268]
although others have not shown benefits [269]. One major
weakness with abdominal blocks is short duration. Con-
ventional bupivacaine and ropivacaine used in traditional
TAP blocks have a short half-life (usually 8–10 h) [270].
Various methods have been used to increase the duration of
abdominal wall blocks including mixing standard local
anaesthetics with dexamethasone [271], dextran [272] and
use of infusion catheters [266]. Liposomal bupivacaine,
initially approved for infiltration and not for nerve blocks,
is currently approved for TAP blocks as the target is an
anatomical musculofascial plane between the internal
oblique and transversus abdominis muscles not a specific
nerve [273].
Summary and recommendation: Small RCTs in laparo-
scopic colorectal and other surgeries show that TAP
blocks reduce opioid consumption and improve recov-
ery. Optimal pain relief appears to depend on the extent
of spread within the fascial plane, which in turn is
dependent on the type, volume, duration of action of
injectate and the accuracy with which the correct plane
is identified. Both ultrasound-guided and laparoscopic
approaches have been described.
Quality of evidence: Moderate
Recommendation grade: TAP blocks in minimally
invasive surgery: Strong
19. Thromboprophylaxis
Older data in traditional perioperative care showed that
without thromboprophylaxis there was a 30% incidence of
asymptomatic deep vein thrombosis (DVT) after colorectal
surgery [274]. Recent reviews of risk factors (high-risk
patients) include ulcerative colitis, advanced malignancy
(Stage III ? IV), hypercoaguable state, steroid use,
advanced age and obesity [275].
All patients benefit from mechanical thromboprophy-
laxis achieved with compression stockings and/or inter-
mittent pneumatic compression (ICP) during
hospitalisation or until mobilised as proven measure to
reduce the incidence of DVT after general surgery even in
the absence of pharmacological treatment [OR 0.27
(0.20–0.38)] [276–278].
Pharmacological thromboprophylaxis with low molec-
ular weight heparin (LMWH) or unfractionated heparin has
been shown to reduce the incidence of symptomatic venous
thromboembolism and also overall mortality with a very
low risk of bleeding complications. A single administration
of LMWH per day was as effective as twice-daily admin-
istration [279, 280]. A combination of ICP together with
pharmacological prophylaxis decreased the incidence of
pulmonary embolism (PE) and DVT when compared with a
single modality at the expense of higher risk for bleeding
complications when comparing to ICP alone [277].
The usefulness of extended thromboprophylaxis (ETP)
for 28 days after colorectal surgery relies on data from
traditional perioperative care. Based on a Cochrane meta-
analysis of four RCTs [279], previous ERAS recommen-
dations and other guidelines (NICE, NHMRC)
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recommended ETP (28 days) for patients having major
cancer surgery in the abdomen or pelvis. However, with
changes in surgical techniques from open to minimally
invasive and advances towards less stress with modern
anaesthesia, the extended prophylaxis regime has been
questioned. A recent report indicates that only 8–27% of
colorectal surgeons followed these traditional recommen-
dations [281]. Furthermore, incidence of symptomatic
VTE, DVT and PE after discharge is reported to be very
low at 0.60–0.73%, 0.29–0.48% and 0.26–0.40%, respec-
tively, in the three largest and recent cohort studies
including 236,066 patients [275, 281]. Also, in non-cancer
surgery, such as after hip replacement surgery, 90-day risk
for VTE was indifferent for short thromboprophylaxis
(1–6 days) as compared with standard ([ 7 days) and
extended ([ 28 days) regimens [282]. So far, RCTs
investigating the benefit or risks of ETP versus shorter
prophylaxis show no reduction in symptomatic DVT,
symptomatic pulmonary emboli or VTE-related death
[281]. However, these studies are heavily underpowered
and cannot answer this clinical question. The clinical value
in that the same studies showed that subclinical thrombosis
were several times more frequent with in-house short-term
prophylaxis compared to 4 weeks is uncertain [281]. Given
the reduction in stress using minimally invasive techniques
and several other stress-reducing ERAS elements com-
bined with the almost immediate mobilisation of the
patients the relevance of older studies can be questioned
and needs to be revisited. Lastly, no specific data are
available supporting the use of ETP in low-risk ERAS
patients.
However, given the seriousness of the complications,
the risk factor spectrum for thrombosis among colorectal
surgery patients and the lack of data showing no risk or a
benefit from shorter or no prophylaxis, the recommenda-
tion needs to continue to rely on current old but available
evidence.
Summary and recommendation:
Patients undergoing major colorectal surgery should
have (I) mechanical thromboprophylaxis by well-fitting
compression stockings and/or intermittent pneumatic
compression until discharge and (II) receive pharmaco-
logical prophylaxis with LMWH once daily for 28 days
after surgery.
Quality of evidence:
Postoperative mechanical thromboprophylaxis: High
– In-hospital or until mobilised: Moderate
Postoperative LMWH: High
– In-hospital or 7 days postop: Low
– 28 days after surgery: Low
Recommendation grade:
Mechanical thromboprophylaxis until discharge: Strong
LMWH In-hospital or 7 days postop: Weak
LMWH until 28 days postop: Strong
20. Postoperative fluid and electrolyte therapy
Intravenous fluid therapy is usually not necessary after
the day of operation for most patients undergoing col-
orectal surgery. Patients should be encouraged to drink
when they are awake and free of nausea after the operation
and an oral diet can usually be started within 4 h after
surgery [202, 283]. If oral fluid intake is tolerated, intra-
venous fluid administration should be discontinued as soon
as feasible, preferably at least by day 1 POD and should be
restarted only if clinical indications exist. In such situations
and in the absence of surgical losses, physiological main-
tenance fluids should be given, when indicated, at a rate of
25–30 ml/kg per day with no more than 70–100 mmol
sodium/day, along with potassium supplements (up to
1 mmol/kg/day) [284]. As long as this volume is not
exceeded, hyponatraemia is very unlikely to occur despite
the provision of hypotonic solutions [285, 286]. Any
ongoing losses (e.g. vomiting or high stoma losses) should
be replaced on a like for like basis for what is being lost in
addition to the maintenance requirement. After ensuring
the patient is normovolaemic, hypotensive patients
receiving epidural analgesia should be treated with vaso-
pressors rather than indiscriminate fluid boluses [287, 288].
It is important that patients are maintained in as near a state
to zero fluid balance as possible in the perioperative period,
as both fluid deficits and overload (of as little as 2.5 L
[289]) can cause adverse effects in the form of increased
postoperative complications, prolonged hospital stay and
higher costs due to increased resource utilisation
[6, 290, 291].
Balanced crystalloids versus 0.9% saline:
There is considerable evidence from physiological
studies that large volumes of intravenous 0.9% saline cause
a hyperchloraemic acidosis, interstitial fluid overload,
impairment of renal haemodynamics and a reduction in
urinary water and sodium excretion as a result of a
reduction in renal blood flow and glomerular filtration rate
[292–296].
Large observational, propensity-matched studies have
suggested 0.9% saline, because of the high chloride con-
tent, may cause harm, especially to the kidney in patients
undergoing surgery [297], critically ill patients [298] and
those with the systemic inflammatory syndrome [299].
Another propensity-matched study has suggested that up to
22% of patients develop acute hyperchloraemia
([ 110 mmol/L) in the postoperative period and that this is
associated with an increased risk of 30-day mortality and
longer LOS than those who do not develop
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hyperchloraemia [300]. However, as there are no large-
scale RCTs yet comparing 0.9% saline with balanced
crystalloids in a surgical population, the current evidence
cannot be regarded as high. In addition, a recent meta-
analysis that was limited by imprecision and studies of a
small sample size has shown that for unselected critically
ill or perioperative adult patients there was no benefit
evidence of low versus high chloride solutions [301].
Management of Oliguria
Oliguria in the adult is usually defined as urine out-
put\ 0.5 ml/kg/h, or\ 500 ml in 24 h, in an adult.
However, urine output and oliguria alone are not reliable
indicators of hypovolaemia in the first 48 h after surgery as
the postoperative metabolic response to stress leads to renal
vasoconstriction and physiological salt and water retention
[302]. Oliguria should be assessed carefully (fluid balance
chart), and a thorough clinical examination performed
before commencing intravenous fluid resuscitation for
dehydration or hypovolaemia, as excess fluid administra-
tion has been associated with acute kidney injury
[303, 304]. If the patient does not demonstrate clinical
signs of hypovolaemia (e.g. tachycardia, hypotension,
sweating, confusion and decreased capillary return), it is
useful to average urine output out over 4 h. A conservative
fluid regimen does not appear to increase the risk of
postoperative oliguria or acute kidney injury [305–308]. In
addition, supplemental intravenous fluids or diuretics do
not improve renal function or protect against acute kidney
injury [304–306, 309]. Indeed, allowing a lower urine
output in the perioperative phase appears safe and results in
significantly reduced administration of intravenous fluid
[308].
Summary and recommendation: Net ‘‘near-zero’’ fluid
and electrolyte balance should be maintained. To cover
pure maintenance needs, hypotonic crystalloids should
be used (rather than isotonic crystalloids, which contain
high concentrations of sodium and cations). For replace-
ment of losses, saline 0.9% and saline-based solutions
should be avoided, with balanced solutions being
preferred. In patients receiving epidural analgesia,
arterial hypotension should be treated with vasopressors
after ensuring the patient is normovolaemic.
Quality of evidence:
Neutral fluid balance: High
Hypotonic crystalloids for maintenance needs: Low
Balanced salt solutions instead of 0.9% saline: Low
Recommendation grade:
‘‘Near-zero’’ fluid balance: Strong
Hypotonic crystalloids for maintenance needs: Strong
0.9% saline should be avoided: Strong (only in hyper-
chloraemic and acidotic patients).
21. Urinary drainage
Urinary drainage during and after colorectal surgery is
used traditionally for two main reasons: prevention of
urinary retention and monitoring of urine output. The
duration of catheterisation is directly related to a risk of
urinary tract infection (UTI) and may hinder postoperative
mobilisation and should therefore be limited. In a RCT of
catheter removal after major abdominal and thoracic sur-
gery on day 1 (n = 105) versus day 4 (n = 110), the risk of
UTI was markedly reduced with early removal (2 vs 14%)
and the risk of retention was low in both groups (8 vs 2%
single in–out catheterisation; 3 vs 0% 24-h catheterisation)
[310]. A large observational study (n = 513) confirms low
retention rates (14%) in patients undergoing colorectal
surgery within an established ERAS protocol that included
early catheter removal [311]. This study highlighted male
gender and postoperative epidural analgesia as important
independent predictors of retention. Thus, tailored removal
of the bladder catheter can be guided by such risk factors.
The importance of closely monitoring the perioperative
urine output to avoid oliguria has recently been challenged.
In renal medicine, oliguria is defined as a daily urine out-
put\ 400 ml, or approximately\ 0.2 ml/kg/h in average
weight adults [312]. In the perioperative setting, oliguria is
traditionally defined as a urine output\ 0.5 ml/kg/h, and
additional fluid is administered to reach above this target.
There are no data to support this practice. A recent RCT
demonstrated that fluid therapy guided by the lower target of
0.2 ml/kg/h during and after colorectal surgery is not only
safe but also spares a significant volume of intravenous
fluids compared with the standard target of 0.5 ml/kg/h
[308]. An hourly measurement of urinary output is therefore
by itself no longer an indication for bladder catheterisation.
Special considerations for pelvic surgery
Patients undergoing pelvic surgery appear to be at par-
ticular risk of postoperative urinary retention. A RCT
performed in the 1990s found retention rates of 25% versus
10% when the transurethral catheter was removed on day 1
versus day 5 after proctectomy [313]. A more recent RCT
of transurethral catheterisation for 1, 3 or 5 days after
pelvic surgery (n = 118) supported a higher risk of reten-
tion with early removal (15, 5 and 10%, respectively)
[314]. The 15–25% urinary retention rate associated with
catheter removal on the first day after pelvic surgery sug-
gests that delaying catheter removal in this group to 2 or
3 days is justified in this group.
Extended bladder catheterisation may be required in
selected cases undergoing complex pelvic reconstructive
surgery. A recent meta-analysis has confirmed that when
the duration of postoperative catheterisation exceeds
5 days, a suprapubic tube or clean intermittent catheteri-
sation are safer alternatives to the standard transurethral
catheter [315].
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Summary and recommendation:
Routine transurethral catheterisation is recommended for
1–3 days after colorectal surgery. The duration should
be individualised based on known risk factors for
retention: male gender, epidural analgesia and pelvic
surgery. Patients at low risk should have routine removal
of catheter on the first day after surgery, while patients
with moderate or high risk require catheterisation for up
to 3 days.
Quality of evidence level: High
Recommendation grade: Strong
22. Prevention of postoperative ileus
Prolonged postoperative ileus is a major contributor to
patient discomfort, delayed discharge and increased cost;
hence, its prevention is a key objective of enhanced
recovery protocols. Many of the core elements of these
protocols, such as (1) limiting opioid administration
through application of multimodal analgesia techniques
(including use of mid-thoracic epidurals and peripheral
nerve blocks), (2) use of minimally invasive surgery, (3)
eliminating routine nasogastric tube placement, and (4)
maintaining fluid balance including goal-directed fluid
therapy, can limit the duration of postoperative ileus [9].
These elements are supported by high-quality evidence and
are discussed elsewhere in these guidelines. This section
focuses on additional interventions and pharmacological
agents that specifically target ileus.
Peripherally acting l-opioid receptor (PAM-OR)
antagonists with limited ability to cross the blood–brain
barrier include alvimopan, methylnaltrexone, naloxone and
naloxegol. These agents can ameliorate opioid-induced
bowel dysfunction without reversing analgesia through
central l-opioid receptor antagonism. Of these agents,
alvimopan is the best studied in the context of limiting
duration of postoperative ileus. This drug is currently
approved by the US Food and Drug Administration (FDA)
but not universally available, for the indication of accel-
erating upper and lower gastrointestinal recovery following
partial large or small bowel resection with primary anas-
tomosis. However, in a recently published systematic
review of eight randomised, placebo-controlled, clinical
trials evaluating of the efficacy of alvimopan in reducing
duration of postoperative ileus following major abdominal
surgery, six of these studies found a reduction with alvi-
mopan administration, whereas two found no difference
among study groups [316]. Each of these studies were
graded as moderate or low in quality and tended to focus on
patients undergoing open surgery. In addition, two ran-
domised, placebo-controlled, clinical trial found no dif-
ference between methylnaltrexone and placebo in
decreasing duration of postoperative ileus following seg-
mental colectomy [317]. Conflicting data on efficacy, costs
and concerns over cardiovascular complications, limit
recommendation for routine use of these agents, particu-
larly in the context of increasingly wide-spread application
of opioid-sparing anaesthesia and analgesia techniques and
of minimally invasive surgery.
Numerous RCTs have evaluated the efficacy of post-
operative gum chewing in reducing duration of postoper-
ative ileus. A Cochrane review of this topic concluded that,
while gum chewing may be associated with mild reduc-
tions in ileus duration, the evidence on this topic is largely
limited to small, poor quality studies [318]; in particular,
most studies lack appropriate blinding of patients and
investigators [319]. Further, the benefits of gum chewing in
the context of ERAS pathways have been unclear.
Recently, a well-designed, large-scale multicentre RCT
evaluating the effects of postoperative gum chewing in
patients undergoing abdominal surgery and on ERAS
pathways was reported [320]. Gum chewing had no impact
on time to first postoperative flatus or bowel movement, on
postoperative length of stay, or on incidence of postoper-
ative complications. Thus, while gum chewing is associ-
ated with little, if any, harm in postoperative patients,
currently available evidence does not support the efficacy
of gum chewing in reducing duration of ileus in patients
undergoing abdominal surgery on ERAS pathways.
Accordingly, its routine inclusion as a component of ERAS
care is not recommended.
Various other agents that have been tested for efficacy in
reducing duration of postoperative ileus, including laxa-
tives and coffee. In prospective controlled trials, reductions
in various indices of postoperative ileus have been
observed to occur with oral bisacodyl administration in
patients undergoing colorectal surgery [321], with oral
magnesium oxide administration in patients undergoing
hysterectomy [322], with oral daikenchuto (a traditional
Japanese herbal medicine) administration in patients
undergoing gastrectomy [323], and with oral coffee
administration in patients undergoing colorectal surgery
[324]. Interestingly, another RCT revealed greater reduc-
tions in indices of postoperative ileus with de-caffeinated
coffee administration than with caffeinated coffee in
patients undergoing left-sided laparoscopic colectomy
[325]. These studies have methodological limitations, and
confirmatory studies are needed before routine application
is recommended. Nevertheless, we recommend against
withholding coffee from postoperative patients who toler-
ate oral liquids.
Summary and recommendation: A multimodal approach
to minimise the development of postoperative ileus
include: limit opioid administration through use of
multimodal anaesthesia and analgesia techniques, use
minimally invasive surgical techniques (when feasible),
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eliminate routine placement of nasogastric tubes and use
goal-directed fluid therapy. Peripherally acting l-opioid
receptor antagonists, chewing gum, bisacodyl, magne-
sium oxide, daikenchuto and coffee have all some
indications of affecting an established ileus.
Quality of evidence:
Multimodal prevention of ileus: High.
Peripherally acting l-opioid receptor antagonists (e.g.
alvimopan): Moderate.
Bisacodyl, magnesium oxide, daikenchuto and coffee:
Low
Recommendation grade: Multimodal prevention of ileus:
Strong. Peripherally acting l-opioid receptor antagonists
(e.g. alvimopan): Weak. Bisacodyl, magnesium oxide,
daikenchuto, and coffee: Weak
23. Postoperative glycaemic control
A hallmark of the physiological response to surgical
trauma is insulin resistance, or so-called pseudodiabetes of
injury, which persists for several weeks after elective sur-
gery [326]. This leads to an osmotic shift of fluid into the
vascular space and an increased availability of glucose for
glucose-dependent tissues such as white blood cells and the
brain. Although hyperglycaemia after surgery was reported
in 1934, it was not until 2001 that negative consequences
of perioperative hyperglycaemia were fully recognised,
with the publication of a large RCT comparing permissive
hyperglycaemia with strict glycaemic control by intensive
insulin therapy [327]. Morbidity and mortality were
decreased in the intervention group.
No further trials of strict glycaemic control in surgical
patients have been reported, although a subgroup analysis
of trauma patients in a multi-centre trial shows similar
results [328]. Intensive insulin therapy can therefore not be
recommended in routine colorectal surgery, but these trials
do highlight the clinical risks posed by perioperative
hyperglycaemia.
In elective surgery, there are opportunities to prevent
insulin resistance from developing in the first place. Sev-
eral interventions that blunt insulin resistance are part of
the ERAS care pathway, including oral preoperative car-
bohydrate treatment, laparoscopic surgery and thoracic
epidural analgesia. A recent large RCT showed that pre-
operative carbohydrates moderated postoperative glucose
concentrations and reduced the need for insulin [124]. Two
trials have shown that surgery within ERAS is associated
with partial or complete attenuation of key stress responses.
In the first, unchanged postoperative nitrogen losses, neu-
tral nitrogen balance, minimal insulin resistance and pre-
served normoglycaemia during feeding were found after
major open colorectal surgery [329]. A recent four-way
randomised study of laparoscopic versus open surgery and
ERAS versus traditional care assessed the independent
effects of laparoscopic surgery and ERAS [191, 330].
ERAS was associated with a blunted stress mediator
response, measured by growth hormone concentration
changes. Nevertheless, observational studies have revealed
that hyperglycaemia remains prevalent during the postop-
erative period, in particular in patients with an increased
preoperative haemoglobin A1c [331]. The association to
postoperative adverse outcomes appears to be the strongest
in subjects without a diagnosis of diabetes [332].
Summary and recommendation:
Hyperglycaemia is a risk factor for complications and
should therefore be avoided. Several interventions in the
ERAS protocol prevent insulin resistance, thereby
improving glycaemic control with no risk of causing
hypoglycaemia. For in patients, insulin should be used
judiciously to maintain blood glucose as low as feasible
with the available resources.
Quality of evidence:
Using stress-reducing elements of ERAS to minimise
hyperglycaemia: Moderate (study quality,
extrapolations).
Insulin treatment in the ICU: Moderate (inconsistency,
uncertain target concentration of glucose).
Glycaemic control (using insulin) in the ward setting:
Low (inconsistency, extrapolations)
Recommendation grade:
Using stress-reducing elements of ERAS to minimise
hyperglycaemia: Strong
Insulin treatment in the ICU (severe hyperglycaemia):
Strong
Insulin treatment in the ICU (mild hyperglycaemia):
Weak (uncertain target concentration of glucose)
Insulin treatment in the ward setting: Weak (risk of
hypoglycaemia, evidence level)
24. Postoperative nutritional care
Postoperative resumption of oral intake.
It has been well established that any delay in the
resumption of normal oral diet after major surgery is
associated with increased rates of infectious complications
and delayed recovery [333]. Early oral diet has been shown
to be safe 4 h after surgery [3] in patients with a new non-
diverted colorectal anastomosis. Some report that low
residue diet, rather than clear liquid diet, after colorectal
surgery is associated with less nausea, faster return of
bowel function, and a shorter hospital stay without
increasing postoperative morbidity when administered in
association with prevention of postoperative ileus [334].
Spontaneous food intake rarely exceeds 1200–1500 kcal/-
day [331]. To reach energy and protein requirements,
additional oral nutritional supplements have been shown to
be useful [335].
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Immunonutrition
Surgical stress can cause an acute depletion of arginine,
which both impairs T cell function and wound healing
[336]. This acute nutritional deficiency is potentially
modifiable and has been the target of nutritional optimi-
sation around the time of surgery. Therefore, supplemen-
tation of enteral feeds with immunomodulators such as L-
arginine, L-glutamine, x-3 fatty acids and nucleotides
(immunonutrition) is thought to modify immune and
inflammatory responses favourably and result in reduced
postoperative infective complications and shorter LOS
[337, 338]. The recent ESPEN guideline on perioperative
nutrition presented an extensive review of multiple RCTs
and meta-analysis and concluded that peri-or at least
postoperative immunonutrition (arginine, omega 3 fatty
acids and ribonucleotides) should be given to malnourished
patients undergoing major cancer surgery [53]. A reduction
in infectious complications was reported in favour of
immunonutrition over standard ONS in two recent
prospective RCTs within an ERAS protocol [339, 340].
Summary and recommendation:
Most patients can and should be offered food and ONS
from the day of surgery. Perioperative immunonutrition in
malnourished patients is beneficial in colorectal cancer
surgery.
Quality of evidence:
Postoperative resumption of oral intake: Moderate
Immunonutrition: Low
Recommendation grade:
Postoperative resumption of oral intake: Strong
Immunonutrition: Strong (no harm)
25. Early Mobilisation
Early mobilisation after abdominal surgery is widely
regarded as an important component of perioperative care
for enhanced recovery. Prolonged bed rest is associated
with risk for developing pulmonary complications,
decreased skeletal muscle strength, thromboembolic com-
plications and insulin resistance [341–343]. Early mobili-
sation has therefore been an integral component of
enhanced recovery after surgery protocols. While there is
strong evidence regarding the harmful effects of immo-
bilisation, evidence is more limited regarding the benefit of
dedicated interventions specifically designed to increase
early mobilisation after surgery.
A recent systematic review of the effect of early
mobilisation protocols on postoperative outcomes follow-
ing abdominal and thoracic surgery evaluated a total of 8
studies [344] (including 3 RCTs and 1 prospective obser-
vational study) in abdominal surgery and 4 (including 3
RCTs and 1 retrospective observational study) in thoracic
surgery. The specific outcomes of interest included post-
operative complications, LOS, gastrointestinal function
recovery, performance-based outcomes and patient-re-
ported outcomes. While not all studies evaluated all out-
comes, for each outcome, only one study could
demonstrate a benefit for the intervention group.
The impact of early mobilisation in critically ill patients
was recently demonstrated in an international multicentre
randomised trial of goal-directed mobilisation versus usual
care in intensive care unit patients [345]. The intervention
arm included basic manoeuvres such as sitting and standing
or stepping in place at the bedside. Compared with usual
care, goal-directed early mobilisation was associated with a
short duration of surgical intensive care unit stay and better
functional mobility at discharge. Moreover, lack of early
mobilisation after abdominal surgery has been associated
with an up to 3.0 (95% confidence interval 1.2–8.0) fold
increased in likelihood of developing a pulmonary com-
plication [346]. Yet the applicability of these findings to
patients who have few limitations for mobility following
elective surgery is uncertain.
Early mobilisation is an essential component of multi-
modality strategies for enhanced recovery after surgery. A
multivariate linear regression analysis of data collected
during the LAFA trial supported the notion that mobilisa-
tion on postoperative days 1, 2 and 3 is a factor signifi-
cantly associated with a successful outcome of ERAS
[191]. However, despite the demonstrated effectiveness of
the ERAS pathways, there remains considerable variation
in the extent to which the different ERAS pathway inter-
ventions are implemented, including with respect to the
implementation of early mobilisation [347, 348]. Although
the degree of compliance to ERAS principles including
early mobilisation has been associated with improved
outcomes [203], a recently reported RCT comparing
facilitated mobilisation during postoperative days 0–3 to a
standard enhanced recovery programme increased out-of-
bed activities but did not improve outcomes [349].
Finally, another important consideration is that failure of
early mobilisation may be due to a variety of factors such
as inadequate control of pain, continued intravenous intake
of fluids, prolonged indwelling urinary catheter, patient
motivation, and pre-existing comorbidities which are likely
themselves associated with poorer outcomes, leading to
question of whether the observed outcomes are associated
with early mobilisation or are due to the underlying factors
that lead to the inability to mobilise.
Taken together, the studies suggest that bedrest should be
discouraged in favour of early mobilisation, but the alloca-
tion of additional resources to implement structured early
mobilisation beyond integration into multimodal enhanced
recovery protocols has not shown to be of benefit.
Summary and recommendation:
Early mobilisation through patient education and
encouragement is an important component of enhanced
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recovery after surgery programmes; prolonged immobili-
sation is associated with a variety of adverse effects and
patients should therefore be mobilised.
Quality of evidence: Moderate
Recommendation grade: Strong
Audit
Audit forms the basis for insights to practice and outcomes.
Countries in Northern Europe and the UK have had a tra-
dition of national audits with yearly reports on basic sur-
gical data and crude outcomes such as major complications
and mortality. Over the years, these have become more or
less mandatory for most surgical procedures. In the USA,
the American College of Surgeons runs the ACS National
Surgical Quality Improvement program (www.facs.org/
quality-programs/acs-nsqip) involving several hundred
hospitals collecting sample outcome data throughout the
surgical spectrum. In many countries, however, there are
no systems available to study or compare outcomes. The
ERASSociety has taken on the mission to spread the use
of audit and to develop systems not only for annual reports,
but for daily use to implement changes and improvements
and to sustain high-level care (www.erassociety.org).
Surgical patients undergoing major operations are most
often treated by a large number of more or less specialised
healthcare professionals delivering a long list of different
care elements. Each caregiver is focused on his/her specific
target with their treatment during that specific period he/
she cares for the patient. The complexity of the patient’s
journey makes it very hard for each and everyone involved
in the care to know what their role is in the bigger picture,
nor how their choices of treatments will affect the patient’s
journey later on. A poor choice in treatment early in the
patient journey will affect the possibilities to deliver other
care elements later on. For instance, if the patient is
overhydrated during the operation, the chances of feeding
the patient orally postoperatively are diminished [285]. For
this reason, it is important to document and feed back to all
involved in the patients care pathway which care is actually
given to the patient throughout and relate that to the out-
comes that the unit delivers. To know this seemingly basic
information there is a need to collect relevant data, analyse
them and feed back in a structured way. A Cochrane
analysis reported that audit and feedback have a significant
effect on healthcare professionals adherence to a given
protocol [350]. Audit and feedback has its best effects
when done repeatedly (monthly), delivered by colleagues
and given both in writing and verbally, with specific targets
for change and for multifaceted interventions.
For ERAS implementation, an early report showed that
a protocol alone was not enough to achieve good outcomes
[351], and with more experience assembled, a recent Del-
phi study suggested the use of standardised audit and
feedback as an important part of an implementation pro-
gramme [352].
There are several reports from different countries
showing that better compliance with ERAS Society
guidelines associates with better 30 day outcomes in terms
of complications and time to discharge and recovery [204]
and even long-term survival [353], which is contrasted by a
recent report from 12 hospitals in central western Europe
showing low adherence and hospitals stays of almost
2 weeks while having had no structured ERAS imple-
mentation or continuous use of audit [348]. While there is
convincing evidence that audit and feedback is important in
implementation of ERAS, there are fewer insights to the
effect of audit and feedback on sustainability of ERAS.
There is, however, one report from the Netherlands where a
successful implementation programme was followed up
several years later when audit had been dropped after the
completion of the programme. The authors found that
compliance had fallen back in 7 of the 10 units investi-
gated, and despite the introduction of minimally invasive
surgery to a large extent, LOS was increased [354].
There are different ways to collect data and to review
them, and some use homemade systems using daily used
software. The ERAS Society has developed the ERAS
Interactive Audit System, which is used in the ERAS
Implementation Programmes worldwide and that is tailored
for use when making changes, sustaining improvements
and for research [204]. It also allows comparisons and
benchmarking.
Summary and recommendation:
Collection of key outcome and process data used for
repeated audit and feedback is essential to drive change for
improvements and to know and control practice. Outcomes
(complications and mortality 30 days) and processes
should be audited and feed back to all healthcare providers
on a regular basis when driving change or implementing
ERAS programmes, as well as for sustaining
improvements.
Quality of evidence: High
Recommendation grade: Strong
Implications of ERAS for nursing practice
Implementation of an ERAS programme can be challeng-
ing for clinical staff. Nurses can often find certain elements
of the process difficult as they are often expected to alter
their practice based on current evidence. ERAS education
is essential to inform and update all members of the clinical
team about all the ERAS interventions and this should
begin at nursing colleges and universities. Regular multi-
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disciplinary conversations need to occur so that the evi-
dence-based recommendations can be implemented effec-
tively. Some research has been conducted on the impact of
ERAS on nursing workload [355, 356] but more qualitative
research would be beneficial to better understand ERAS
from a nursing perspective.
Documentation is also a crucial factor in ERAS imple-
mentation—the documents need to be concise and agreed
locally so that the nurse can progress the patient along the
pathway autonomously and meet ERAS targets more
effectively.
Setting discharge criteria and daily goals is important.
Highlighting these goals to the patient before surgery is a
key to avoid unrealistic expectations and keep both the
patient and relatives informed that short LOS is to be
expected. Patient follow-up is integral to an ERAS pro-
gramme—patient’s should be given discharge advice and
should be contacted by the ERAS team, particularly if the
patient is discharged within 2–4 days of surgery. This
provides an added ‘safety net’ for patients so that they and
their clinicians know that they are being reviewed fol-
lowing discharge.
Comment
The current guidelines from the ERAS society for clinical
perioperative care of patients undergoing elective col-
orectal surgery are the fourth in order published since the
ERAS study group was formed in 2001. A continually
growing evidence base in perioperative medicine necessi-
tates frequent updates in the knowledge base for continu-
ous training and development in practise for those involved
in the treatment of surgical patients. The current evidence-
based recommendations were evaluated according to the
GRADE system and the quality of evidence for each item
were crosschecked by several authors in the author list.
Even though the guidelines are based on formal criteria
on how to evaluate the evidence base behind perioperative
treatment, it cannot be ignored that grading of evidence is
demanding and also difficult. That the evidence base is low
in certain research areas can have many reasons and does
not obviously mean that an effect is missing or that the
outcome of one item is worse than another item. Thus, a
strong recommendation together with low evidence may
seem conflicting. However, current review of the evidence
must be put into the perspective of the level of evidence in
general for common medical practices and treatments and
that the evidence for components in the ERAS protocol is
at a level that is commonly in use throughout medicine
today.
The quality of evidence and recommendations in these
guidelines are intended to be used by experienced
clinicians either as a tool to implement an ERAS protocol
or to upgrade a protocol that already has been imple-
mented. However, in clinical practice one has to remember
that many of the healthcare professionals who are involved
in perioperative care may have limited knowledge in ERAS
care pathways and therefore need an overview of the topic
more quickly. In the current guidelines, we have renewed
the layout so that the reader is able to obtain an efficient
overview with the graphs and still find more details on
different items in the text. We hope that the way the ERAS
items are listed in this document will make the guidelines
easier to read as they follow the natural perioperative
journey.
Previous versions of these guidelines have been exten-
sively tested in different parts of the world and shown to be
efficacious [203]. Continuous issues when discussing
ERAS programmes are which elements are the most
important for outcome from surgery, as some may argue
that only a few are needed. These questions have no evi-
dence-based simple answer. Some units may use certain
aspects of perioperative care and then as other evidence
elements are added, they will improve their outcomes.
Other units may have a completely different starting point.
What has been shown, however, is that with increased
compliance to the items within the whole ERAS protocol,
short-term outcomes are improved [3, 203], and may also
have impact on improving long-term survival [353].
Therefore, all elements that may have an impact on out-
come, greater or smaller, have been included in the
guidelines.
The lack of updated evidence is a potential weakness for
some of the recommendations as well as the fact that many
studies were not performed under optimal ERAS condi-
tions. While it would be ideal to test all elements in optimal
perioperative conditions, this will not reflect real-life
perioperative care of today. By reviewing national data-
bases, large registries or cohort studies it is obvious that
key outcome data such as LOS and complications differ
significantly between centres in different countries. This
difference also applies to centres practising the ERAS
protocol. In addition, traditions and recommendations in
one country may vary from another. This may be especially
true when the evidence base is weak. The intention of this
update is thus to provide a comprehensive overview of the
optimal perioperative care of patients undergoing major
colorectal surgery as found in the current up to date med-
ical literature.
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